合成路线1
该中间体在本合成路线中的序号:
(III) The ozonolysis of cylcoheptene (I) with O3 in dichloromethane, followed by a treatment with methanol and p-toluenesulfonic acid gives 7,7-dimethoxyheptanal (II), which is condensed with methoxycarbonyl-methylenetriphenylphosphorane (III) in methanol yielding methyl 9,9-dimethoxy-2-nonenoate (IV). The condensation of (IV) with 2(S)-(tetrahydropyranyloxy)propanal (V) by means of LDA in THF/HMPA affords the beta-hydroxyester (VI), which is cyclized by means of p-toluenesulfonic acid and mesyl chloride affording the furanone (VII). The hydrolysis of the acetal group of (VII) with Amberlyst 15 gives the aldehyde (VIII), which is condensed with the phosphorane (IX) yielding the unsaturated thioester (X). The cyclization of (XV) by means of Et2AlCl in toluene affords the tricyclic thioester (XI), which is reduced with RaNi in ethanol/ethyl ether affording the carbinol (XII). The reaction of (XII) with tosyl chloride and thiophenol provides the pheylsulfanyl derivative (XIII), which is reduced at the lactone group with iBu2AlH in ethyl ether giving the lactol (XIV). The methylation of the lactol (XIV) with BF3/Et2O and methanol yields the cyclic ketal (XV), which is finally oxidized with meta-chloroperbenzoic acid (MCPBA) in dichloromethane to afford the desired tricyclic sulfone intermediate (XVI).
【1】
Hart, D.J.and Wu, W.-L.; Total syntheses of (+)-Himbacine and (-)-Himbeline. J Am Chem Soc 1995, 117, 9369.
|
【2】
Wu, W.-L.; Hart, D.J.; Li, J.; Applications of Organosulfur Chemistry to Organic Synthesis: Total Synthesis of (+)-Himbeline and (-)-Himbacine. J Org Chem 1997, 62, 5023.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33179 |
1-cycloheptene
|
628-92-2 |
C7H12 |
详情 | 详情
|
(II) |
33180 |
7,7-dimethoxyheptanal
|
|
C9H18O3 |
详情 |
详情
|
(III) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(IV) |
33181 |
methyl (E)-9,9-dimethoxy-2-nonenoate
|
|
C12H22O4 |
详情 |
详情
|
(V) |
33182 |
(2R)-2-methyl-3-(tetrahydro-2H-pyran-2-yloxy)propanal
|
|
C9H16O3 |
详情 |
详情
|
(VI) |
33183 |
methyl (E)-2-[(2R)-1-hydroxy-2-methyl-3-(tetrahydro-2H-pyran-2-yloxy)propyl]-9,9-dimethoxy-3-nonenoate
|
|
C21H38O7 |
详情 |
详情
|
(VII) |
33184 |
(5S)-3-[(E)-7,7-dimethoxy-1-heptenyl]-5-methyl-2(5H)-furanone
|
|
C14H22O4 |
详情 |
详情
|
(VIII) |
33185 |
(E)-7-[(5S)-5-methyl-2-oxo-2,5-dihydro-3-furanyl]-6-heptenal
|
|
C12H16O3 |
详情 |
详情
|
(IX) |
33186 |
S-ethyl 2-(triphenylphosphoranylidene)ethanethioate
|
|
C22H21OPS |
详情 |
详情
|
(X) |
33187 |
S-ethyl (2E,8E)-9-[(5S)-5-methyl-2-oxo-2,5-dihydro-3-furanyl]-2,8-nonadienethioate
|
|
C16H22O3S |
详情 |
详情
|
(XI) |
33188 |
S-ethyl (3S,3aR,4R,4aS,8aS)-3-methyl-1-oxo-1,3,3a,4,4a,5,6,7,8,8a-decahydronaphtho[2,3-c]furan-4-carbothioate
|
|
C16H22O3S |
详情 |
详情
|
(XII) |
33189 |
(3S,3aR,4R,4aS,8aR,9aS)-4-(hydroxymethyl)-3-methyldecahydronaphtho[2,3-c]furan-1(3H)-one
|
|
C14H22O3 |
详情 |
详情
|
(XIII) |
33190 |
(3S,3aS,4R,4aS,8aR,9aS)-3-methyl-4-[(phenylsulfanyl)methyl]decahydronaphtho[2,3-c]furan-1(3H)-one
|
|
C20H26O2S |
详情 |
详情
|
(XIV) |
33191 |
(1S,3S,3aS,4R,4aS,8aR,9aS)-3-methyl-4-[(phenylsulfanyl)methyl]dodecahydronaphtho[2,3-c]furan-1-ol
|
|
C20H28O2S |
详情 |
详情
|
(XV) |
33192 |
(1S,3S,3aS,4R,4aS,8aR,9aS)-3-methyl-4-[(phenylsulfanyl)methyl]dodecahydronaphtho[2,3-c]furan-1-yl methyl ether; (1S,3S,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-4-[(phenylsulfanyl)methyl]dodecahydronaphtho[2,3-c]furan
|
|
C21H30O2S |
详情 |
详情
|
(XVI) |
33193 |
[(1S,3S,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyldodecahydronaphtho[2,3-c]furan-4-yl]methyl phenyl sulfone; (1S,3S,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-4-[(phenylsulfonyl)methyl]dodecahydronaphtho[2,3-c]furan
|
|
C21H30O4S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) The intermediate (XVI) has been obtained as follows: The ozonolysis of (2S,3S,4S)-2,4-dimethyl-1-(tert-butyldimethylsilyloxy)-5-hexen-3-ol (I) with O3 in DMSO gives the aldehyde (II), which is condensed with phosphorane (III) to yield the chiral heptenoic acid methyl ester (IV). The reaction of (IV) with benzaldehyde (V) by means of KHMDS affords the cyclic ketal (VI), which is desilylated with HF to provide the carbinol (VII). The oxidation of (VII) in methanol gives the dimethylacetal (VIII), which is treated with CSA in methanol to yield the tetrahydropyranylacetic acid methyl ester (IX). The silylation of the OH group of (IX) with Tbdms-OTf affords the silyl ether (X), which is hydrolyzed with LiOH to the corresponding free acetic acid (XI). The condensation of (XI) with N,O-dimethylhydroxylamine (XII) by means of DCC and HOBT provides the methoxyamide (XIII), which is treated with phenylsulfanyltrimethylsilane (XIV), ZnI2 and tetrabutylammonium iodide to give the phenylsulfanyl derivative (XV). Finally, the methoxyamide group of (XV) is reduced with LiAlH4 to afford the target acetaldehyde derivative (XVI).
【1】
Hung, D.T.; et al.; Syntheses of discodermolides useful for investigating microtubule binding and stabilization. J Am Chem Soc 1996, 118, 45, 11054.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
42688 |
(2S,3S,4S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2,4-dimethyl-5-hexen-3-ol
|
|
C14H30O2Si |
详情 |
详情
|
(II) |
42689 |
(2R,3R,4S)-5-[[tert-butyl(dimethyl)silyl]oxy]-3-hydroxy-2,4-dimethylpentanal
|
|
C13H28O3Si |
详情 |
详情
|
(III) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(IV) |
42690 |
methyl (E,4S,5S,6S)-7-[[tert-butyl(dimethyl)silyl]oxy]-5-hydroxy-4,6-dimethyl-2-heptenoate
|
|
C16H32O4Si |
详情 |
详情
|
(V) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(VI) |
42691 |
methyl 2-[(4S,5R,6R)-6-((1S)-2-[[tert-butyl(dimethyl)silyl]oxy]-1-methylethyl)-5-methyl-2-phenyl-1,3-dioxan-4-yl]acetate
|
|
C23H38O5Si |
详情 |
详情
|
(VII) |
42692 |
methyl 2-[(4S,5R,6R)-6-[(1S)-2-hydroxy-1-methylethyl]-5-methyl-2-phenyl-1,3-dioxan-4-yl]acetate
|
|
C17H24O5 |
详情 |
详情
|
(VIII) |
42693 |
methyl 2-[(4S,5R,6S)-6-[(1R)-2,2-dimethoxy-1-methylethyl]-5-methyl-2-phenyl-1,3-dioxan-4-yl]acetate
|
|
C19H28O6 |
详情 |
详情
|
(IX) |
42694 |
methyl 2-[(2S,3R,4S,5R)-4-hydroxy-6-methoxy-3,5-dimethyltetrahydro-2H-pyran-2-yl]acetate
|
|
C11H20O5 |
详情 |
详情
|
(X) |
42695 |
methyl 2-((2S,3S,4S,5R)-4-[[tert-butyl(dimethyl)silyl]oxy]-6-methoxy-3,5-dimethyltetrahydro-2H-pyran-2-yl)acetate
|
|
C17H34O5Si |
详情 |
详情
|
(XI) |
42696 |
2-((2S,3S,4S,5R)-4-[[tert-butyl(dimethyl)silyl]oxy]-6-methoxy-3,5-dimethyltetrahydro-2H-pyran-2-yl)acetic acid
|
|
C16H32O5Si |
详情 |
详情
|
(XII) |
13361 |
(Methoxyamino)methane; N,O-Dimethylhydroxylamine
|
1117-97-1 |
C2H7NO |
详情 | 详情
|
(XIII) |
42697 |
2-((2S,3S,4S,5R)-4-[[tert-butyl(dimethyl)silyl]oxy]-6-methoxy-3,5-dimethyltetrahydro-2H-pyran-2-yl)-N-methoxy-N-methylacetamide
|
|
C18H37NO5Si |
详情 |
详情
|
(XIV) |
42698 |
trimethyl(phenylsulfanyl)silane; phenyl trimethylsilyl sulfide
|
4551-15-9 |
C9H14SSi |
详情 | 详情
|
(XV) |
42699 |
2-[(2S,3S,4S,5R,6S)-4-[[tert-butyl(dimethyl)silyl]oxy]-3,5-dimethyl-6-(phenylsulfanyl)tetrahydro-2H-pyran-2-yl]-N-methoxy-N-methylacetamide
|
|
C23H39NO4SSi |
详情 |
详情
|
(XVI) |
42700 |
2-[(2S,3S,4S,5R,6S)-4-[[tert-butyl(dimethyl)silyl]oxy]-3,5-dimethyl-6-(phenylsulfanyl)tetrahydro-2H-pyran-2-yl]acetaldehyde
|
|
C21H34O3SSi |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XXIX) The condensation of propane-1,3-diol (XXV) with benzaldehyde by means of p-toluenesulfonic acid gives the corresponding cyclic acetal (XXVI), which is reduced with diisobutylaluminum hydride in toluene yielding 3-benzoyloxy-1-propanol (XXVII). The oxidation of (XXVII) with oxalyl chloride as before affords the corresponding aldehyde (XXVIII), which is submitted to a Wittig condensation with 2-(triphenylphosphoranylidene)acetic acid methyl ester (XXIX) giving (E)-5-benzyloxy-2-pentenoic acid methyl ester (XXX). The hydrolysis of (XXX) with NaOH in THF-water yields the corresponding acid (XXXI), which is condensed with pivaloyl chloride (XXXII) to afford the mixed anhydride (XXXIII). The condensation of (XXXIII) with 4(S)-benzyloxazolidin-2-one (XXXIV) by means of BuLi in THF gives 4(S)-benzyl-3-[5-benzyloxy-2(E)-pentenoyl]oxazolidin-2-one (XXXV), which is submitted to a Diels-Alder cycloaddition with cyclopentadiene (XXXVI) to yield 4-benzyl-3-[(3R,4R,5S,6S)-5-(2-benzyloxyethyl)bicyclo[2.2.1]hept-2-en-4-ylcarbonyl]oxazolidin-2-one (XXXVII). Hydrogenation of (XXXVII) with H2 over Pt in ethylacetate, followed by hydrolysis with H2O2 and LiOH affords (1R,2R,3S,4S)-3-(2-benzyloxyethyl)bicyclo[2.2.1]heptane-2-carboxylic acid (XXXVIII). The formation of the corresponding azide with ethyl chloroformate and sodium azide followed by degradation in refluxing toluene gives the amine (XXXIX), which is acylated with benzenesulfonyl chloride as before yielding the sulfonamide (XL). The deprotection of (XL) by hydrogenolysis with H2 over Pd/C in ethanol affords the substituted ethanol (XLI). Oxidation of (XLI) with oxalyl chloride as before gives the aldehyde (XLII), which is finally submitted to a Wittig condensation with 4-carboxybutyl triphenylphosphonium bromide and t-BuOK to yield acid (XIV) enantiomerically pure, already obtained.
【1】
Wong and F.F. Sun (Eds.), Raven Press, Ltd., New York 1989, 19, 659-62. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIV) |
14674 |
(Z)-7-[(1R,2S,3S,4S)-3-[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-yl]-5-heptenoic acid
|
|
C20H27NO4S |
详情 |
详情
|
(XXV) |
14685 |
1,3-propanediol; Trimethylene Glycol
|
504-63-2 |
C3H8O2 |
详情 | 详情
|
(XXVI) |
14686 |
2-phenyl-1,3-dioxane
|
|
C10H12O2 |
详情 |
详情
|
(XXVII) |
14687 |
3-(benzyloxy)-1-propanol; 3-(Benzyloxy)propanol
|
4799-68-2 |
C10H14O2 |
详情 | 详情
|
(XXVIII) |
14688 |
3-(benzyloxy)propanal
|
|
C10H12O2 |
详情 |
详情
|
(XXIX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XXX) |
14690 |
Methyl (E)-5-(benzyloxy)-2-pentenoate
|
|
C13H16O3 |
详情 |
详情
|
(XXXI) |
14691 |
(E)-5-(Benzyloxy)-2-pentenoic acid
|
|
C12H14O3 |
详情 |
详情
|
(XXXII) |
13597 |
2,2-Dimethylpropanoyl chloride; Pivaloyl chloride
|
3282-30-2 |
C5H9ClO |
详情 | 详情
|
(XXXIII) |
14693 |
(E)-4-(Benzyloxy)-2-pentenoic 1,1-Dimethylpropionic anhydride
|
|
C17H22O4 |
详情 |
详情
|
(XXXIV) |
14694 |
(S)-4-Benzyl-2-oxazolidinone; (4S)-4-Benzyl-1,3-oxazolan-2-one; (S)-(-)-4-Benzyl-2-oxazolidinone
|
90719-32-7 |
C10H11NO2 |
详情 | 详情
|
(XXXV) |
14695 |
(4S)-4-benzyl-3-[(E)-5-(benzyloxy)-2-pentenoyl]-1,3-oxazolan-2-one
|
|
C22H23NO4 |
详情 |
详情
|
(XXXVI) |
11183 |
1,3-Cyclopentadiene
|
|
C5H6 |
详情 |
详情
|
(XXXVII) |
14697 |
(4S)-4-benzyl-3-([(1R,2S,3S,4S)-3-[2-(benzyloxy)ethyl]bicyclo[2.2.1]hept-5-en-2-yl]carbonyl)-1,3-oxazolan-2-one
|
|
C27H29NO4 |
详情 |
详情
|
(XXXVIII) |
14698 |
(1S,2S,3S,4R)-3-[2-(benzyloxy)ethyl]bicyclo[2.2.1]heptane-2-carboxylic acid
|
|
C17H22O3 |
详情 |
详情
|
(XXXIX) |
14699 |
(1S,2S,3S,4R)-3-[2-(benzyloxy)ethyl]bicyclo[2.2.1]heptan-2-amine; (1S,2S,3S,4R)-3-[2-(benzyloxy)ethyl]bicyclo[2.2.1]hept-2-ylamine
|
|
C16H23NO |
详情 |
详情
|
(XL) |
14700 |
N-[(1S,2S,3S,4R)-3-[2-(benzyloxy)ethyl]bicyclo[2.2.1]hept-2-yl]benzenesulfonamide
|
|
C22H27NO3S |
详情 |
详情
|
(XLI) |
14701 |
N-[(1S,2S,3S,4R)-3-(2-hydroxyethyl)bicyclo[2.2.1]hept-2-yl]benzenesulfonamide
|
|
C15H21NO3S |
详情 |
详情
|
(XLII) |
14673 |
N-[(1S,2S,3S,4R)-3-(2-oxoethyl)bicyclo[2.2.1]hept-2-yl]benzenesulfonamide
|
|
C15H19NO3S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
Scheme shows the synthesis of Galardin(TM) from the two starting materials, 4-methyl-2-oxopentanoic acid sodium salt (I) and tert-butyloxycarbonyl-L-tryptophan (V).
The pentanoic acid is protected as a benzyl ester and then condensed with the ylide methyl (triphenylphosphoranylidene)acetate to give methyl 3-benzyloxycarbonyl-5-methyl-2-hexenoate (III). Deprotection and reduction of (III) gives the key intermediate 2(R,S)-2-methoxycarbonylmethyl-4-methylpentanoic acid (IV) in high overall yield.
The protected L-tryptophan starting material (V) is coupled with methylamine to give (VI), which is deprotected to give the second key intermediate, L-tryptophan methylamide hydrochloride (VII).
Coupling of (IV) and (VII) gives the mixture of diastereomers 2(R,S)-2-methoxycarbonylmethyl-4-methylpentanoyl-L-tryptophan methylamide. Low-pressure column chromatography on silica gel gives 2(R)-2-methoxycarbonylmethyl-4-methylpentanoyl-L-tryptophan methylamide (VIII) in high yield. Direct hydroxaminolysis of the methyl ester (VIII) in methanol in the presence of potassium hydroxide gives crude Galardin(TM). Recrystallization gives the drug substance.
【1】
Bodden, M.K.; Engler, J.A.; Moore, W.G.I.; Windsor, L.J.; Birkedal-Hansen, H.; Birkedal-Hansen, B.; DeCarlo, A.; Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993, 4, 2, 197-250.
|
【2】
Galardy, R.E.; Galardin (TM). Drugs Fut 1993, 18, 12, 1109.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(I) |
16110 |
sodium 4-methyl-2-oxopentanoate
|
|
C6H9NaO3 |
详情 |
详情
|
(II) |
16111 |
benzyl 4-methyl-2-oxopentanoate
|
|
C13H16O3 |
详情 |
详情
|
(III) |
16112 |
1-benzyl 4-methyl (E)-2-isobutyl-2-butenedioate
|
|
C16H20O4 |
详情 |
详情
|
(IV) |
16113 |
2-(2-methoxy-2-oxoethyl)-4-methylpentanoic acid
|
|
C9H16O4 |
详情 |
详情
|
(V) |
16114 |
N-alpha-t-BOC-L-tryptophan; (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-indol-3-yl)propionic acid
|
13139-14-5 |
C16H20N2O4 |
详情 | 详情
|
(VI) |
16115 |
tert-butyl N-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]carbamate
|
|
C17H23N3O3 |
详情 |
详情
|
(VII) |
16116 |
(2S)-2-amino-3-(1H-indol-3-yl)-N-methylpropanamide
|
|
C12H15N3O |
详情 |
详情
|
(VIII) |
16117 |
methyl (3R)-3-([[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]amino]carbonyl)-5-methylhexanoate
|
|
C21H29N3O4 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) An enantioselective total synthesis of (+)-calanolide A has been reported: The silylation of 2'-hydroxy-4',6'-dimethoxybutyrophenone (I) with TIPS-Cl by means of benzylltriethylammonium chloride and NaOH in benzene gives the silyl ether (II), which is demethylated with BCl3 in dichloromethane yielding 2'-hydroxy-4'-methoxy-6'-(triisopropylsilyloxy)butyrophenone (III). The Wittig condensation of (III) with the phosphorane (IV) in N,N-diethylaniline with simultaneous cyclization, affords the benzopyranone (V), which is submitted to a Friedel-Crafts condensation with the acyl chloride (VI) by means of SnCl4 in dichloromethane to provide the 8-acylbenzopyranone (VII). The desilylation of (VII) by means of TBAF in THF/dichloromethane gives the 5-hydroxy compound (VIII) which is submitted to a propargylation with alcohol (IX) and DBU and then to a Claisen rearrangement with N,N-diethylaniline affording the pyrano-benzopyran (X). Demethylation of (X) with MgI2 in refluxing benzene gives the phenol (XI), which is submitted to a (-)-quinine-catalyzed asymmetric intramolecular oxo-Michael addition in chlorobenzene yielding an 80:20 mixture of the chiral cis- and trans-benzotripyrans (XII) (94% ee) and (XIII), respectively. Since the desired compound is the minor component (XIII), the preceding mixture is treated with MgI2 in refluxing benzene to afford an equilibrated 50:50 mixture that is separated by chromatography, and the undesired cis-isomer can be recycled by repeating the MgI2 treatment. The enantiomerically rich trans-isomer (XIII) is finally reduced with LiAlH(Ot-Bu)3 in THF.
【1】
Tanaka, T.; et al.; Enantioselective total synthesis of anti HIV-1 active (+)-calanolide A through a quinine-catalyzed asymmetric intramolecular oxo-Michael addition. Tetrahedron Lett 2000, 41, 52, 10229.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45726 |
1-(2-hydroxy-4,6-dimethoxyphenyl)-1-butanone
|
|
C12H16O4 |
详情 |
详情
|
(II) |
45727 |
1-[2,4-dimethoxy-6-[(triisopropylsilyl)oxy]phenyl]-1-butanone
|
|
C21H36O4Si |
详情 |
详情
|
(III) |
45728 |
1-[2-hydroxy-4-methoxy-6-[(triisopropylsilyl)oxy]phenyl]-1-butanone
|
|
C20H34O4Si |
详情 |
详情
|
(IV) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(V) |
45729 |
7-methoxy-4-propyl-5-[(triisopropylsilyl)oxy]-2H-chromen-2-one
|
|
C22H34O4Si |
详情 |
详情
|
(VI) |
45730 |
Tigloyl chloride; (E)-2-methyl-2-butenoyl chloride
|
35660-94-7 |
C5H7ClO |
详情 | 详情
|
(VII) |
45731 |
7-methoxy-8-[(E)-2-methyl-2-butenoyl]-4-propyl-5-[(triisopropylsilyl)oxy]-2H-chromen-2-one
|
|
C27H40O5Si |
详情 |
详情
|
(VIII) |
45732 |
5-hydroxy-7-methoxy-8-[(E)-2-methyl-2-butenoyl]-4-propyl-2H-chromen-2-one
|
|
C18H20O5 |
详情 |
详情
|
(IX) |
22416 |
3-chloro-3-methyl-1-butyne
|
1111-97-3 |
C5H7Cl |
详情 | 详情
|
(X) |
45733 |
5-methoxy-2,2-dimethyl-6-[(E)-2-methyl-2-butenoyl]-10-propyl-2H,8H-pyrano[2,3-f]chromen-8-one
|
|
C23H26O5 |
详情 |
详情
|
(XI) |
45734 |
5-hydroxy-2,2-dimethyl-6-[(E)-2-methyl-2-butenoyl]-10-propyl-2H,8H-pyrano[2,3-f]chromen-8-one
|
|
C22H24O5 |
详情 |
详情
|
(XII) |
22411 |
(10R,11S)-6,6,10,11-tetramethyl-4-propyl-10,11-dihydro-2H,6H,12H-dipyrano[2,3-f:2,3-h]chromene-2,12-dione
|
|
C22H24O5 |
详情 |
详情
|
(XIII) |
22410 |
(10R,11R)-6,6,10,11-tetramethyl-4-propyl-10,11-dihydro-2H,6H,12H-dipyrano[2,3-f:2,3-h]chromene-2,12-dione
|
|
C22H24O5 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(XIII) Intermediate (VII) can be obtained by following two different pathways:
1. Hydrogenation of 4-pyridine acetic acid (IX) over PtO2 in AcOH affords piperidinyl derivative (X), which is then protected with Boc2O and NaOH in THF to yield (XI). Reduction of the CO2H group of (XI) with BH3.THF in THF gives alcohol (XII), which is then subjected to Swern oxidation with oxalyl chloride and DMSO in CH2Cl2, followed by reaction with Wittig reagent (XIII) and N-methyl morpholine (NMM), to provide crotonate (XIV). Hydrogenation of (XIV) over Pd/C in MeOH furnishes methyl butyrate (XV), which is finally hydrolyzed with NaOH in MeOH.
2. Alternatively, intermediate (VII) can be obtained by reaction of diethyl malonate (XVI) with 4-vinylpyridine and NaH in EtOH to afford derivative (XVIII), which is hydrolyzed and decarboxylated with HCl/H2O and then hydrogenated over PtO2 to provide piperidine derivative (XIX). Finally, (XIX) is protected by reaction with Boc2O and NaOH in THF.
【1】
Molino, B.F.; Klein, S.I.; Czekaj, M.; et al.; Design of a new class of orally active fibrinogen receptor antagonists. J Med Chem 1998, 41, 14, 2492.
|
【2】
Klein, S.I.; Molino, B.F. (Aventis Pharma SA); Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides. EP 0812205; JP 1997507213; US 5866685; WO 9510295 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
45852 |
4-[1-(tert-butoxycarbonyl)-4-piperidinyl]butyric acid
|
|
C14H25NO4 |
详情 |
详情
|
(IX) |
17883 |
2-(4-pyridinyl)acetic acid
|
28356-58-3 |
C7H7NO2 |
详情 | 详情
|
(X) |
45854 |
2-(4-piperidinyl)acetic acid; 4-piperidinylacetic acid
|
51052-78-9 |
C7H13NO2 |
详情 | 详情
|
(XI) |
19346 |
1-Boc-piperidin-4-ylacetic acid; 2-[1-(tert-butoxycarbonyl)-4-piperidinyl]acetic acid
|
157688-46-5 |
C12H21NO4 |
详情 | 详情
|
(XII) |
43453 |
tert-butyl 4-(2-hydroxyethyl)-1-piperidinecarboxylate
|
|
C12H23NO3 |
详情 |
详情
|
(XIII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XIV) |
45855 |
tert-butyl 4-[(E)-4-methoxy-4-oxo-2-butenyl]-1-piperidinecarboxylate
|
|
C15H25NO4 |
详情 |
详情
|
(XV) |
45856 |
tert-butyl 4-(4-methoxy-4-oxobutyl)-1-piperidinecarboxylate
|
|
C15H27NO4 |
详情 |
详情
|
(XVI) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(XVII) |
45857 |
4-vinylpyridine
|
|
C7H7N |
详情 |
详情
|
(XVIII) |
45858 |
diethyl 2-[2-(4-pyridinyl)ethyl]malonate
|
|
C14H19NO4 |
详情 |
详情
|
(XIX) |
45859 |
4-(4-piperidinyl)butyric acid
|
|
C9H17NO2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(IX) The intermediate 4-(4-chlorophenylsulfonyl)aminocyclohexanone (V) was prepared by two synthetic ways. Reductive condensation of 4,4-diethoxycyclohexanone (I) with benzylamine in the presence of sodium triacetoxyborohydride and AcOH provided the benzylcyclohexylamine (II). Further hydrogenolysis of the N-benzyl group of (II) in the presence of Pd/C and oxalic acid yielded cyclohexylamine (III) as the oxalate salt. Sulfonamide (V) was then obtained by condensation with 4-chlorophenylsulfonyl chloride (IV), followed by hydrolysis of the diethyl acetal with aqueous HCl.
lternatively, treatment of trans-4-aminocyclohexanol hydrochloride (VI) with sulfonyl chloride (IV) in the presence of Et3N provided the sulfonamide (VII), which was subsequently oxidized with chromic anhydride and H2SO4 to the target ketone (V).
Condensation of this intermediate (V) with ethyl formate in the presence of NaH produced the hydroxymethylene cyclohexanone (VIII), which was submitted to a Wittig reaction with phosphorane (IX) to give the cyclohexylidenpropanoic ester (X). Cyclization of this compound using anhydrous p-toluenesulfonic acid in refluxing toluene furnished pyranone (XI), which by subsequent bromination in acetic acid yielded the 3-bromopyranone (XII). The key tetrahydronaphthalene system (XIV) was then obtained by Diels-Alder reaction with methyl propiolate (XIII) with concomitant decarboxylation at 200 C. Finally, the ester function of (XIV) was reduced to alcohol (XV) with LiAlH4.
【1】
Cimetière, B.; Dubuffet, T.; Landras, C.; Descombes, J.J.; Simonet, S.; Verbeuren, T.J.; Lavielle, G.; New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors. Bioorg Med Chem Lett 1998, 8, 11, 1381. |
【2】
Lavielle, G.; Dubuffet, T.; Muller, O.; Laubie, M.; Verbeuren, T.; Simonet, S.; Descombes, J.-J. (ADIR et Cie.); 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivs. as antithrombotic agents. CA 2118102; EP 0648741; FR 2711139; JP 1995188155 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19576 |
4,4-diethoxycyclohexanone
|
|
C10H18O3 |
详情 |
详情
|
(II) |
19577 |
N-benzyl-4,4-diethoxycyclohexanamine; N-benzyl-N-(4,4-diethoxycyclohexyl)amine
|
|
C17H27NO2 |
详情 |
详情
|
(III) |
19578 |
4,4-diethoxycyclohexanamine; 4,4-diethoxycyclohexylamine
|
|
C10H21NO2 |
详情 |
详情
|
(V) |
19580 |
4-chloro-N-(4-oxocyclohexyl)benzenesulfonamide
|
|
C12H14ClNO3S |
详情 |
详情
|
(VI) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
(VII) |
19582 |
4-chloro-N-(4-hydroxycyclohexyl)benzenesulfonamide
|
|
C12H16ClNO3S |
详情 |
详情
|
(VIII) |
19583 |
4-chloro-N-[3-[(Z)-hydroxymethylidene]-4-oxocyclohexyl]benzenesulfonamide
|
|
C13H14ClNO4S |
详情 |
详情
|
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(X) |
19585 |
methyl 3-(5-[[(4-chlorophenyl)sulfonyl]amino]-2-oxocyclohexylidene)propanoate
|
|
C16H18ClNO5S |
详情 |
详情
|
(XI) |
19586 |
4-chloro-N-(2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)benzenesulfonamide
|
|
C15H14ClNO4S |
详情 |
详情
|
(XII) |
19587 |
N-(3-bromo-2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)-4-chlorobenzenesulfonamide
|
|
C15H13BrClNO4S |
详情 |
详情
|
(XIII) |
19588 |
methyl propiolate
|
922-67-8 |
C4H4O2 |
详情 | 详情
|
(XIV) |
19589 |
methyl 3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-5,6,7,8-tetrahydro-1-naphthalenecarboxylate
|
|
C18H17BrClNO4S |
详情 |
详情
|
(XV) |
19590 |
N-[7-bromo-5-(hydroxymethyl)-1,2,3,4-tetrahydro-2-naphthalenyl]-4-chlorobenzenesulfonamide
|
|
C17H17BrClNO3S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IX) The alcohol (XV) was oxidized with 4-benzylpyridinium dichromate to the aldehyde (XVI). 3-(Tributylstannylmethyl)pyridine (XVIII), prepared from lithiated 3-picoline (XVII) and Bu3SnCl in the presence of HMPA, was coupled to bromotetrahydronaphthalene (XVI) under palladium catalysis to provide the pyridylmethyl derivative (XIX). Wittig reaction of (XIX) with phosphorane (IX) gave acrylate (XX), which was reduced with NaBH4 and CoCl2 to the tetrahydronaphthylpropionic ester (XXI). Finally, the ester group of (XXI) was hydrolyzed with NaOH in MeOH-H2O to give the title acid.
【1】
Cimetière, B.; Dubuffet, T.; Landras, C.; Descombes, J.J.; Simonet, S.; Verbeuren, T.J.; Lavielle, G.; New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors. Bioorg Med Chem Lett 1998, 8, 11, 1381. |
【2】
Lavielle, G.; Dubuffet, T.; Muller, O.; Laubie, M.; Verbeuren, T.; Simonet, S.; Descombes, J.-J. (ADIR et Cie.); 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivs. as antithrombotic agents. CA 2118102; EP 0648741; FR 2711139; JP 1995188155 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XVI) |
19591 |
N-(7-bromo-5-formyl-1,2,3,4-tetrahydro-2-naphthalenyl)-4-chlorobenzenesulfonamide
|
|
C17H15BrClNO3S |
详情 |
详情
|
(XVII) |
19592 |
(3-pyridinylmethyl)lithium
|
|
C6H6LiN |
详情 |
详情
|
(XVIII) |
19572 |
3-[(tributylstannyl)methyl]pyridine
|
|
C18H33NSn |
详情 |
详情
|
(XIX) |
19594 |
4-chloro-N-[5-formyl-7-(3-pyridinylmethyl)-1,2,3,4-tetrahydro-2-naphthalenyl]benzenesulfonamide
|
|
C23H21ClN2O3S |
详情 |
详情
|
(XX) |
19595 |
methyl (E)-3-[6-[[(4-chlorophenyl)sulfonyl]amino]-3-(3-pyridinylmethyl)-5,6,7,8-tetrahydro-1-naphthalenyl]-2-propenoate
|
|
C26H25ClN2O4S |
详情 |
详情
|
(XXI) |
19596 |
methyl 3-[6-[[(4-chlorophenyl)sulfonyl]amino]-3-(3-pyridinylmethyl)-5,6,7,8-tetrahydro-1-naphthalenyl]propanoate
|
|
C26H27ClN2O4S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VIII) The reaction of 4(R)-hydroxy-L-proline (I) with allyl chloroformate (II) and NaOH gives the protected proline (III), which is esterified with MeOH and sulfuric acid to yield the methyl prolinate (IV). The reaction of (IV) with Ms-Cl and TEA affords the mesylate (V), which is reduced with NaBH4 to provide the prolinol derivative (VI). The Swern oxidation of alcohol (VI) gives the carbaldehyde (VII), which is condensed with the phosphorane (VIII) by means of NaOMe, yielding the acrylate (IX). The reduction of (IX) with DIBAL affords the substituted allyl alcohol (X), which is condensed with phthalimide (XI) by means of PPh3 and DIAD to provide the adduct (XII). The cleavage of the phthalimido group of (XII) with hydrazine gives the amino derivative (XIII), which is treated with Ms-Cl and TEA to yield the sulfonamide (XIV). The reaction of (XIV) with potassium thioacetate affords the acetylsulfanyl pyrrolidine (XV), which is hydrolyzed with HCl to provide the thiol (XVI). The condensation of the thiol (XVI) with the carbapenem derivative (XVII) by means of DIEA gives the protected adduct (XVIII), which is finally treated with Pd(II) and Bu3SnH in order to eliminate the allyl protecting groups.
The intermediate carbapenem derivative (XVII) has been obtained from azetidinone (XIX) by known methods as indicated in the scheme.
【1】
Kwon, J.W.; Kim, W.B.; Kim, S.H.; Lee, M.G.; DA-1131. Drugs Fut 2001, 26, 11, 1040.
|
【2】
Shin, H.C.; Kim, J.Y.; Kim, G.W.; Lee, C.W.; Lim, J.I.; Chang, M.S.; Kim, N.S.; Kim, D.S.; Im, W.B.; Rhee, J.K. (Dong-A Pharmaceutical Co., Ltd.); Carbapenem derivs. and processes for preparing the same. WO 9514692 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14489 |
(2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylic acid; L-Hydroxyproline
|
51-35-4 |
C5H9NO3 |
详情 | 详情
|
(II) |
38115 |
3-[(chlorocarbonyl)oxy]-1-propene
|
2937-50-0 |
C4H5ClO2 |
详情 | 详情
|
(III) |
47730 |
(2S,4R)-1-[(allyloxy)carbonyl]-4-hydroxy-2-pyrrolidinecarboxylic acid
|
|
C9H13NO5 |
详情 |
详情
|
(IV) |
42200 |
1-allyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate
|
|
C10H15NO5 |
详情 |
详情
|
(V) |
42201 |
1-allyl 2-methyl (2S,4R)-4-[(methylsulfonyl)oxy]-1,2-pyrrolidinedicarboxylate
|
|
C11H17NO7S |
详情 |
详情
|
(VI) |
42202 |
allyl (2S,4R)-2-(hydroxymethyl)-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C10H17NO6S |
详情 |
详情
|
(VII) |
49446 |
allyl (2S,4R)-2-formyl-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C10H15NO6S |
详情 |
详情
|
(VIII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(IX) |
49447 |
allyl (2S,4R)-2-[(E)-3-methoxy-3-oxo-1-propenyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C13H19NO7S |
详情 |
详情
|
(X) |
49448 |
allyl (2S,4R)-2-[(E)-3-hydroxy-1-propenyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C12H19NO6S |
详情 |
详情
|
(XI) |
12376 |
Phthalimide; 1H-Isoindole-1,3(2H)-dione; Isoindole-1,3-dione;Phthalic dicarboximide;Phenylimide;Isoindole-1,3-dione |
85-41-6 |
C8H5NO2 |
详情 | 详情
|
(XII) |
49449 |
allyl (2S,4R)-2-[(E)-3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-1-propenyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C20H22N2O7S |
详情 |
详情
|
(XIII) |
49450 |
allyl (2S,4R)-2-[(E)-3-amino-1-propenyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C12H20N2O5S |
详情 |
详情
|
(XIV) |
50598 |
allyl (2S,4R)-2-[(E)-3-[(methylsulfonyl)amino]-1-propenyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylate
|
|
C13H22N2O7S2 |
详情 |
详情
|
(XV) |
49451 |
allyl (2S,4S)-4-(acetylsulfanyl)-2-[(E)-3-[(methylsulfonyl)amino]-1-propenyl]-1-pyrrolidinecarboxylate
|
|
C14H22N2O5S2 |
详情 |
详情
|
(XVI) |
49452 |
allyl (2S,4S)-2-[(E)-3-[(methylsulfonyl)amino]-1-propenyl]-4-sulfanyl-1-pyrrolidinecarboxylate
|
|
C12H20N2O4S2 |
详情 |
详情
|
(XVII) |
32617 |
allyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C25H26NO8P |
详情 |
详情
|
(XVIII) |
49454 |
allyl (4R,5S,6S)-3-[((3S,5S)-1-[(allyloxy)carbonyl]-5-[(E)-3-[(methylsulfonyl)amino]-1-propenyl]pyrrolidinyl)sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C25H35N3O8S2 |
详情 |
详情
|
(XIX) |
11687 |
(2R,3R)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetanyl acetate
|
|
C13H25NO4Si |
详情 |
详情
|
(XX) |
50599 |
|
|
C17H27N3O6Si |
详情 |
详情
|
(XXI) |
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(VII) In a different synthetic strategy, the known Garner's aldehyde (I) is subjected to a Wittig reaction with phosphorane (II) to give the unsaturated ester (III), which is subsequently hydrogenated, producing (IV) as an inseparable mixture of diastereoisomers. Oxazolidine hydrolysis in (IV), followed by cyclization under acidic conditions leads to lactone (V). This is then converted to the thiolactone (VI) upon treatment with Lawesson's reagent in hot toluene. Condensation of thiolactone (VI) with the Wittig reagent (VII), followed by double bond isomerization in the presence of DBU furnishes the dihydropyran derivative (VIII). Stereoselective hydrogenation of the double bond of (VIII) with PtO2 gives rise to the desired all-cis isomer (IX). The methyl vester group of (IX) is then reduced to aldehyde (X) by means of DIBAL in cold toluene.
【1】
Horigome, M.; Motoyoshi, H.; Watanabe, H.; Kitahara, T.; A synthesis of FR901464. Tetrahedron Lett 2001, 42, 46, 8207.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62140 |
tert-butyl (4S,5R)-4-formyl-2,2,5-trimethyl-1,3-oxazolidine-3-carboxylate
|
|
C12H21NO4 |
详情 |
详情
|
(II) |
37071 |
ethyl 2-(triphenylphosphoranylidene)propanoate
|
5717-37-3 |
C23H23O2P |
详情 | 详情
|
(III) |
62141 |
tert-butyl (4R,5R)-4-[(E)-3-ethoxy-2-methyl-3-oxo-1-propenyl]-2,2,5-trimethyl-1,3-oxazolidine-3-carboxylate
|
|
C17H29NO5 |
详情 |
详情
|
(IV) |
62142 |
tert-butyl (4R,5R)-4-(3-ethoxy-2-methyl-3-oxopropyl)-2,2,5-trimethyl-1,3-oxazolidine-3-carboxylate
|
|
C17H31NO5 |
详情 |
详情
|
(V) |
62143 |
tert-butyl (2R,3R)-2,5-dimethyl-6-oxotetrahydro-2H-pyran-3-ylcarbamate
|
|
C12H21NO4 |
详情 |
详情
|
(VI) |
62144 |
tert-butyl (2R,3R,5R)-2,5-dimethyl-6-thioxotetrahydro-2H-pyran-3-ylcarbamate
|
|
C12H21NO3S |
详情 |
详情
|
(VII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(VIII) |
62145 |
methyl 2-{(2R,3R)-3-[(tert-butoxycarbonyl)amino]-2,5-dimethyl-3,4-dihydro-2H-pyran-6-yl}acetate
|
|
C15H25NO5 |
详情 |
详情
|
(IX) |
62146 |
methyl 2-{(2S,3S,5R,6R)-5-[(tert-butoxycarbonyl)amino]-3,6-dimethyltetrahydro-2H-pyran-2-yl}acetate
|
|
C15H27NO5 |
详情 |
详情
|
(X) |
62147 |
tert-butyl (2R,3R,5S,6S)-2,5-dimethyl-6-(2-oxoethyl)tetrahydro-2H-pyran-3-ylcarbamate
|
|
C14H25NO4 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
Wittig reaction of N-(benzyloxycarbonyl)-L-phenylalaninal (I) with methyl (triphenylphosphoranylidene)acetate produced unsaturated ester (II). Double bond reduction in (II) with concomitant cyclization and N-deprotection upon treatment with Mg in MeOH furnished (R)-5-benzyl-2-pyrrolidinone (III), which was further protected as the N-Boc derivative (IV) (1). Alkylation of (IV) with benzyl bromide in the presence of LDA in THF at -78 C provided the trans-3,5-dimethylpyrrolidinone (V) as the predominant diastereoisomer. After Boc group cleavage using trifluoroacetic acid, pyrrolidinone (VI) was coupled with epoxide (VII) yielding adduct (VIII). The acetonide protecting group of (VIII) was finally hydrolyzed with HCl to give the title compound.
【1】
Kazmierski, W.; Andrews, W. III; Baker, C.; et al.; Heterocyclic isosteres of the P1/P2 domain of amprenavir: Discovery of novel, picomolar HIV-1 protease inhibitors. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 126.
|
【2】
Tung, R.D.; Salituro, F.G.; Deininger, D.D.; Bhisetti, G.R.; Baker, C.T.; Spaltenstein, A.; Kazmierski, W.M.; Andrews, C.W. III (Vertex Pharmaceuticals Inc.); Aspartyl protease inhibitors. JP 2000501111; US 5945413; WO 9727180 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
|
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(I) |
16586 |
benzyl N-[(1S)-1-benzyl-2-oxoethyl]carbamate
|
|
C17H17NO3 |
详情 |
详情
|
(II) |
38970 |
methyl (E,4S)-4-[[(benzyloxy)carbonyl]amino]-5-phenyl-2-pentenoate
|
|
C20H21NO4 |
详情 |
详情
|
(III) |
38971 |
(5R)-5-benzyl-2-pyrrolidinone
|
|
C11H13NO |
详情 |
详情
|
(IV) |
38972 |
tert-butyl (2R)-2-benzyl-5-oxo-1-pyrrolidinecarboxylate
|
|
C16H21NO3 |
详情 |
详情
|
(V) |
38973 |
tert-butyl (3S,5R)-3,5-dibenzyl-2-oxo-1-pyrrolidinecarboxylate
|
|
C23H27NO3 |
详情 |
详情
|
(VI) |
38974 |
(3S,5R)-3,5-dibenzyl-2-pyrrolidinone
|
|
C18H19NO |
详情 |
详情
|
(VII) |
16243 |
(2R)-1-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-2-benzyl-3-[(2S)oxiranyl]-1-propanone
|
|
C24H27NO3 |
详情 |
详情
|
(VIII) |
38975 |
(3S,5R)-1-[(2S,4R)-5-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-4-benzyl-2-hydroxy-5-oxopentyl]-3,5-dibenzyl-2-pyrrolidinone
|
|
C42H46N2O4 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XVII) Methyl 6-methylnicotinate (XII) was condensed with 4-pyridinecarboxaldehyde (XIII) in AcOH-Ac2O at 120 C to produce (XIV). Then, ester group was reduced with LiAlH4 to alcohol (XV), and this was subsequently oxidized with DMSO and SO3-pyridine complex to give aldehyde (XVI). Wittig reaction with phosphorane (XVII) afforded ester (XVIII), which was saponified to yield acid (XIX). Finally, coupling of acid (XIX) with amine (XI) in the presence of EDC and HOBt provided the title amide.
【1】
Abe, Y.; Kayakiri, H.; Satoh, S.; Inoue, T.; Sawada, Y.; Inamura, N.; Asano, M.; Aramori, I.; Hatori, C.; Sawai, H.; Oku, T.; Tanaka, H.; A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a]pyridine moiety. J Med Chem 1998, 41, 21, 4062. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
18600 |
2-amino-N-(2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl)-N-methylacetamide
|
|
C20H19Cl2N3O2 |
详情 |
详情
|
(XII) |
14160 |
methyl 6-methylnicotinate
|
5470-70-2 |
C8H9NO2 |
详情 | 详情
|
(XIII) |
17203 |
4-Pyridinecarboxaldehyde; isonicotinaldehyde
|
872-85-5 |
C6H5NO |
详情 | 详情
|
(XIV) |
18603 |
methyl 6-[(E)-2-(4-pyridinyl)ethenyl]nicotinate
|
|
C14H12N2O2 |
详情 |
详情
|
(XV) |
18604 |
[6-[(E)-2-(4-pyridinyl)ethenyl]-3-pyridinyl]methanol
|
|
C13H12N2O |
详情 |
详情
|
(XVI) |
18605 |
6-[(E)-2-(4-pyridinyl)ethenyl]nicotinaldehyde
|
|
C13H10N2O |
详情 |
详情
|
(XVII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XVIII) |
18607 |
methyl (E)-3-[6-[(E)-2-(4-pyridinyl)ethenyl]-3-pyridinyl]-2-propenoate
|
|
C16H14N2O2 |
详情 |
详情
|
(XIX) |
18608 |
(E)-3-[6-[(E)-2-(4-pyridinyl)ethenyl]-3-pyridinyl]-2-propenoic acid
|
|
C15H12N2O2 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IX) The cyclization of L-serine (I) with pivalaldehyde (II) by means of LDA in THF gives the oxazolidine (III), which is acylated with formic and acetic anhydride yielding the N-formyloxazolidine (IV). The reaction of (IV) with LDA affords the chiral enol (V), which is treated with allyl bromide in THF to give the chiral 4-allyloxazolidine (VI). Cleavage of the oxazolidine ring with acetyl chloride and treatment with benzyl chloroformate yields the protected chiral 2-allylserine (VII), which is oxidized with oxalyl chloride to the corresponding aldehyde (VIII). The Wittig condensation of (VIII) with triphenylphosphoranylideneacetic acid methyl ester (IX) affords the intermediate (X), which is submitted to UV irradiation with an Hanovia medium pressure mercury lamp through a Pyrex filter in benzene containing benzophenone. A mixture of isomeric bicyclic compounds from which the desired compound (XI) is isolated by column chromatography. The hydrogenation of (IX) with H2 over Pd/C in methanol provides the bicyclic aminoester (XII), which is finally hydrolyzed with 6N HCl.
【1】
von Diester, S.; et al.; Stereoselektive Alkylierung an C(alpha) von Serin, Glycerinsaure, Threonin und Weinsaure uber heterocyclische Enolate mit exocyclischer Doppelbindung. Helv Chim Acta 1987, 70, 1194-1216.
|
【2】
Kozikowski, A.P.; et al.; Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. J Med Chem 1998, 41, 10, 1641.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
19797 |
Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal
|
630-19-3 |
C5H10O |
详情 | 详情
|
(III) |
36839 |
methyl (4S)-2-(tert-butyl)-1,3-oxazolidine-4-carboxylate
|
|
C9H17NO3 |
详情 |
详情
|
(IV) |
36840 |
methyl (4S)-2-(tert-butyl)-3-formyl-1,3-oxazolidine-4-carboxylate
|
|
C10H17NO4 |
详情 |
详情
|
(V) |
36841 |
lithium [(2R)-2-(tert-butyl)-3-formyl-1,3-oxazolidin-4-ylidene](methoxy)methanolate
|
|
C10H16LiNO4 |
详情 |
详情
|
(VI) |
36842 |
methyl (2R,4S)-4-allyl-2-(tert-butyl)-3-formyl-1,3-oxazolidine-4-carboxylate
|
|
C13H21NO4 |
详情 |
详情
|
(VII) |
36843 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-2-(hydroxymethyl)-4-pentenoate
|
|
C15H19NO5 |
详情 |
详情
|
(VIII) |
36844 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-2-(2-oxoethyl)-4-pentenoate
|
|
C16H19NO5 |
详情 |
详情
|
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(X) |
36845 |
dimethyl (E,4S)-4-allyl-4-[[(benzyloxy)carbonyl]amino]-2-pentenedioate
|
|
C18H21NO6 |
详情 |
详情
|
(XI) |
36846 |
dimethyl (1R,2S,4R,5S)-2-[[(benzyloxy)carbonyl]amino]bicyclo[2.1.1]hexane-2,5-dicarboxylate
|
|
C18H21NO6 |
详情 |
详情
|
(XII) |
36847 |
dimethyl (1R,2S,4R,5S)-2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylate
|
|
C10H15NO4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(IX) The intermediate 4-(4-chlorophenylsulfonyl)aminocyclohexanone (V) was prepared by two synthetic ways:
1) Reductive condensation of 4,4-diethoxycyclohexanone (I) with benzylamine in the presence of sodium triacetoxyborohydride and AcOH provided the benzylcyclohexylamine (II). Further hydrogenolysis of the N-benzyl group of (III) in the presence of Pd/C and oxalic acid yielded cyclohexylamine (III) as the oxalate salt. Sulfonamide (V) was then obtained by condensation with 4-chlorophenylsulfonyl chloride (IV), followed by hydrolysis of the diethyl acetal with aqueous HCl.
2) Alternatively, treatment of trans-4-aminocyclohexanol hydrochloride (VI) with sulfonyl chloride (IV) in the presence of Et3N provided the sulfonamide (VII), which was subsequently oxidized with chromic anhydride and H2SO4 to the target ketone (V).
3) Condensation of this intermediate with ethyl formate in the presence of NaH produced the hydroxymethylene cyclohexanone (VIII), which was submitted to a Wittig reaction with phosphorane (IX) to give the cyclohexylidenpropanoic ester (X). Cyclization of this compound using anhydrous p-toluenesulfonic acid in refluxing toluene furnished pyranone (XI), which by subsequent bromination in acetic acid yielded the 3-bromopyranone (XII) (1). The key tetrahydronaphthalene system (XIV) was then obtained by Diels-Alder reaction with refluxing methyl hexynoate (XIII) with concomitant decarboxylation. The ester function of (XIV) was reduced to alcohol (XV) with LiAlH4.
【1】
Cimetière, B.; Dubuffet, T.; Landras, C.; Descombes, J.J.; Simonet, S.; Verbeuren, T.J.; Lavielle, G.; New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors. Bioorg Med Chem Lett 1998, 8, 11, 1381. |
【2】
Lavielle, G.; Dubuffet, T.; Muller, O.; Laubie, M.; Verbeuren, T.; Simonet, S.; Descombes, J.-J. (ADIR et Cie.); 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivs. as antithrombotic agents. CA 2118102; EP 0648741; FR 2711139; JP 1995188155 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19576 |
4,4-diethoxycyclohexanone
|
|
C10H18O3 |
详情 |
详情
|
(II) |
19577 |
N-benzyl-4,4-diethoxycyclohexanamine; N-benzyl-N-(4,4-diethoxycyclohexyl)amine
|
|
C17H27NO2 |
详情 |
详情
|
(III) |
19578 |
4,4-diethoxycyclohexanamine; 4,4-diethoxycyclohexylamine
|
|
C10H21NO2 |
详情 |
详情
|
(IV) |
15787 |
4-chlorobenzenesulfonyl chloride;4-chlorobenzene-1-sulfonyl chloride |
98-60-2 |
C6H4Cl2O2S |
详情 | 详情
|
(V) |
19580 |
4-chloro-N-(4-oxocyclohexyl)benzenesulfonamide
|
|
C12H14ClNO3S |
详情 |
详情
|
(VI) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
(VII) |
19582 |
4-chloro-N-(4-hydroxycyclohexyl)benzenesulfonamide
|
|
C12H16ClNO3S |
详情 |
详情
|
(VIII) |
19583 |
4-chloro-N-[3-[(Z)-hydroxymethylidene]-4-oxocyclohexyl]benzenesulfonamide
|
|
C13H14ClNO4S |
详情 |
详情
|
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(X) |
19585 |
methyl 3-(5-[[(4-chlorophenyl)sulfonyl]amino]-2-oxocyclohexylidene)propanoate
|
|
C16H18ClNO5S |
详情 |
详情
|
(XI) |
19586 |
4-chloro-N-(2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)benzenesulfonamide
|
|
C15H14ClNO4S |
详情 |
详情
|
(XII) |
19587 |
N-(3-bromo-2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)-4-chlorobenzenesulfonamide
|
|
C15H13BrClNO4S |
详情 |
详情
|
(XIII) |
19609 |
methyl 2-hexynoate
|
18937-79-6 |
C7H10O2 |
详情 | 详情
|
(XIV) |
19610 |
methyl 3-bromo-6-[[(4-chlorophenyl)sulfonyl]amino]-2-propyl-5,6,7,8-tetrahydro-1-naphthalenecarboxylate
|
|
C21H23BrClNO4S |
详情 |
详情
|
(XV) |
19611 |
N-[7-bromo-5-(hydroxymethyl)-6-propyl-1,2,3,4-tetrahydro-2-naphthalenyl]-4-chlorobenzenesulfonamide
|
|
C20H23BrClNO3S |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(IX) Then group of (XV) was oxidized with 4-benzylpyridinium dichromate to the aldehyde (XVI). 3-(Tributylstannylmethyl)pyridine (XVIII), prepared from lithiated 3-picoline (XVII) and Bu3SnCl in the presence of HMPA, was coupled to bromotetrahydronaphthalene (XVI) under palladium catalysis to provide the pyridylmethyl derivative (XIX). Wittig reaction of (XIX) with phosphorane (IX) gave acrylate (XX), which was reduced with SmI2 or with NaBH4 and CoCl2 to the tetrahydronaphthylpropionic ester (XXI). Finally, the ester group of (XXI) was hydrolyzed with NaOH in MeOH-H2O to give the title acid.
【1】
Cimetière, B.; Dubuffet, T.; Landras, C.; Descombes, J.J.; Simonet, S.; Verbeuren, T.J.; Lavielle, G.; New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors. Bioorg Med Chem Lett 1998, 8, 11, 1381. |
【2】
Lavielle, G.; Dubuffet, T.; Muller, O.; Laubie, M.; Verbeuren, T.; Simonet, S.; Descombes, J.-J. (ADIR et Cie.); 1,2,3,4-Tetrahydronaphthalene, chroman and thiochroman derivs. as antithrombotic agents. CA 2118102; EP 0648741; FR 2711139; JP 1995188155 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XV) |
19611 |
N-[7-bromo-5-(hydroxymethyl)-6-propyl-1,2,3,4-tetrahydro-2-naphthalenyl]-4-chlorobenzenesulfonamide
|
|
C20H23BrClNO3S |
详情 |
详情
|
(XVI) |
19612 |
N-(7-bromo-5-formyl-6-propyl-1,2,3,4-tetrahydro-2-naphthalenyl)-4-chlorobenzenesulfonamide
|
|
C20H21BrClNO3S |
详情 |
详情
|
(XVII) |
19592 |
(3-pyridinylmethyl)lithium
|
|
C6H6LiN |
详情 |
详情
|
(XVIII) |
19572 |
3-[(tributylstannyl)methyl]pyridine
|
|
C18H33NSn |
详情 |
详情
|
(XIX) |
19615 |
4-chloro-N-[5-formyl-6-propyl-7-(3-pyridinylmethyl)-1,2,3,4-tetrahydro-2-naphthalenyl]benzenesulfonamide
|
|
C26H27ClN2O3S |
详情 |
详情
|
(XX) |
19616 |
methyl (E)-3-[6-[[(4-chlorophenyl)sulfonyl]amino]-2-propyl-3-(3-pyridinylmethyl)-5,6,7,8-tetrahydro-1-naphthalenyl]-2-propenoate
|
|
C29H31ClN2O4S |
详情 |
详情
|
(XXI) |
19617 |
methyl 3-[6-[[(4-chlorophenyl)sulfonyl]amino]-2-propyl-3-(3-pyridinylmethyl)-5,6,7,8-tetrahydro-1-naphthalenyl]propanoate
|
|
C29H33ClN2O4S |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) The target FR-165649 has been obtained by condensation of cinnamic acid (V) with amine (XIII) using EDC and HOBt as coupling agents. The two intermediates (V) and (XIII) have been obtained as follows:
1) Wittig reaction of 4-formylbenzoic acid (I) and methyl (triphenylphosphoranylidene)acetate (II) in THF gave methyl 4-carboxycinnamate (III), which was converted into amide (IV) by reaction with methylamine hydrochloride in the presence of EDC and HOBt. Further hydrolysis of the ester group with NaOH provided 4-(methylcarbamoyl)cinnamic acid (V).
2) The alkylation of 8-hydroxy-2-methylquinoline (VI) with benzylic chloride (VII) in the presence of NaH and a catalytic amount of tetrabutylammonium iodide in DMF afforded ether (VIII). Subsequent reduction of the nitro group with iron powder and HCl in refluxing aqueous methanol gave amine (IX), which was coupled with phthalimidoacetyl chloride (X) in the presence of DMAP in a mixture of N-methylpyrrolidone and pyridine to yield amide (XI). Then, alkylation at the amide N with CH3I and NaH provided (XII), and further hydrazinolysis of the phthalimido group yielded the primary amine (XIII). Finally, the target amide was obtained by condensation of cinnamic acid (V) with amine (XIII) using EDC and HOBt as the coupling reagents.
【1】
Oku, T.; Kayakiri, H.; Satoh, S.; Abe, Y.; Sawada, Y.; Inoue, T.; Tanaka, H. (Fujisawa Pharmaceutical Co., Ltd.); Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists. EP 0807105; JP 1998507764; WO 9613485 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18922 |
4-formylbenzoic acid
|
619-66-9 |
C8H6O3 |
详情 | 详情
|
(II) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(III) |
18924 |
4-[(E)-3-methoxy-3-oxo-1-propenyl]benzoic acid
|
|
C11H10O4 |
详情 |
详情
|
(IV) |
18925 |
methyl (E)-3-[4-[(methylamino)carbonyl]phenyl]-2-propenoate
|
|
C12H13NO3 |
详情 |
详情
|
(V) |
18926 |
(E)-3-[4-[(methylamino)carbonyl]phenyl]-2-propenoic acid
|
|
C11H11NO3 |
详情 |
详情
|
(VI) |
18598 |
2-methyl-8-quinolinol
|
826-81-3 |
C10H9NO |
详情 | 详情
|
(VII) |
18928 |
1,3-dichloro-2-(chloromethyl)-4-nitrobenzene
|
|
C7H4Cl3NO2 |
详情 |
详情
|
(VIII) |
18929 |
2,6-dichloro-3-nitrobenzyl 2-methyl-8-quinolinyl ether; 8-[(2,6-dichloro-3-nitrobenzyl)oxy]-2-methylquinoline
|
|
C17H12Cl2N2O3 |
详情 |
详情
|
(IX) |
18930 |
2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenylamine; 2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]aniline
|
|
C17H14Cl2N2O |
详情 |
详情
|
(X) |
10278 |
2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl chloride
|
6780-38-7 |
C10H6ClNO3 |
详情 | 详情
|
(XI) |
18932 |
N-(2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide
|
|
C27H19Cl2N3O4 |
详情 |
详情
|
(XII) |
18599 |
N-(2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-methylacetamide
|
|
C28H21Cl2N3O4 |
详情 |
详情
|
(XIII) |
18600 |
2-amino-N-(2,4-dichloro-3-[[(2-methyl-8-quinolinyl)oxy]methyl]phenyl)-N-methylacetamide
|
|
C20H19Cl2N3O2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(XI) On the other hand, Wittig condensation of isobutyraldehyde (X) with methyl (triphenylphosphoranylidene)acetate (XI) afforded (E)-4-methylpent-2-enoic acid methyl ester (XII). Sharpless catalytic asymmetric dihydroxylation of (XII) gave diol (XIII). Condensation of diol (XIII) with trimethyl orthobenzoate in the presence of BF3.Et2O, followed by treatment of the crude cyclic orthoester with acetyl bromide produced bromo ester (XIV). The required alpha-amino group was then introduced by nucleophilic displacement of the bromide of (XIV) with NaN3 in DMSO, followed by catalytic hydrogenation of the resulting azide (XV). The intermediate amino ester (XVI) was then rearranged to hydroxy amide (XVII) upon refluxing in EtOAc. Cyclization of (XVII) to the required trans oxazoline (XVIII) was then achieved by treatment with p-toluenesulfonic acid in boiling toluene.
【1】
Soucy, F.; et al.; A novel and efficient synthesis of a highly active analogue clasto-lactacystin beta-lactone. J Am Chem Soc 1999, 121, 43, 9967.
|
【2】
Plamondon, L.; Soucy, F.; Behnke, M.; Roush, W.; Synthesis of clasto-lactacystin beta-lactone and analogs thereof. WO 9909006 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(XI) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XII) |
37799 |
methyl (E)-4-methyl-2-pentenoate
|
|
C7H12O2 |
详情 |
详情
|
(XIII) |
37800 |
methyl (2S,3R)-2,3-dihydroxy-4-methylpentanoate
|
|
C7H14O4 |
详情 |
详情
|
(XIV) |
37801 |
(1S,2S)-2-bromo-1-isopropyl-3-methoxy-3-oxopropyl benzoate
|
|
C14H17BrO4 |
详情 |
详情
|
(XV) |
37802 |
(1S,2R)-2-azido-1-isopropyl-3-methoxy-3-oxopropyl benzoate
|
|
C14H17N3O4 |
详情 |
详情
|
(XVI) |
37803 |
(1S,2R)-2-amino-1-isopropyl-3-methoxy-3-oxopropyl benzoate
|
|
C14H19NO4 |
详情 |
详情
|
(XVII) |
37804 |
methyl (2R,3S)-2-(benzoylamino)-3-hydroxy-4-methylpentanoate
|
|
C14H19NO4 |
详情 |
详情
|
(XVIII) |
37805 |
methyl (4R,5S)-5-isopropyl-2-phenyl-4,5-dihydro-1,3-oxazole-4-carboxylate
|
|
C14H17NO3 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(VIII) Diels-Alder condensation of benzopyran (I) with methyl (trimethylsilyl)propynoate (II) gave rise to tetrahydronaphthalene (III). After reduction of the ester group of (III) with LiAlH4, the resulting alcohol (IV) was further oxidized to aldehyde (V) by means of 4-benzylpyridinium dichromate. Treatment of (V) with iodine monochloride produced iodonaphthalene (VI). Subsequent reaction of (VI) with vinyl tributyltin and palladium tetrakis(triphenylphosphine) yielded the vinyl naphthalene (VII). Wittig reaction of (VIII with (carbomethoxymethylidene)triphenylphosphorane (VIII) gave the arylpropenoate ester (IX), which was reduced to the saturated ester (X) employing samarium iodide.
【1】
Lavielle, G.; Cimetiere, B.; Verbeuren, T.; Simonet, S.; Descombes, J.-J. (ADIR et Cie.); Nouveaux dérivés de benzènsessulfonylamine, leur procédé depréparation et les compositions pharmaceutiques qui les contiennent. EP 0864561 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
24920 |
tributyl(vinyl)stannane;Tributylvinylstannane;Vinyltributylstannane |
7486-35-3 |
C14H30Sn |
详情 | 详情
|
(I) |
19586 |
4-chloro-N-(2-oxo-5,6,7,8-tetrahydro-2H-chromen-6-yl)benzenesulfonamide
|
|
C15H14ClNO4S |
详情 |
详情
|
(II) |
32594 |
methyl 3-(trimethylsilyl)-2-propynoate
|
|
C7H12O2Si |
详情 |
详情
|
(III) |
32595 |
methyl 6-[[(4-chlorophenyl)sulfonyl]amino]-2-(trimethylsilyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxylate
|
|
C21H26ClNO4SSi |
详情 |
详情
|
(IV) |
32596 |
4-chloro-N-[5-(hydroxymethyl)-6-(trimethylsilyl)-1,2,3,4-tetrahydro-2-naphthalenyl]benzenesulfonamide
|
|
C20H26ClNO3SSi |
详情 |
详情
|
(V) |
32597 |
4-chloro-N-[5-formyl-6-(trimethylsilyl)-1,2,3,4-tetrahydro-2-naphthalenyl]benzenesulfonamide
|
|
C20H24ClNO3SSi |
详情 |
详情
|
(VI) |
19571 |
4-chloro-N-(5-formyl-6-iodo-1,2,3,4-tetrahydro-2-naphthalenyl)benzenesulfonamide
|
|
C17H15ClINO3S |
详情 |
详情
|
(VII) |
32598 |
4-chloro-N-(5-formyl-6-vinyl-1,2,3,4-tetrahydro-2-naphthalenyl)benzenesulfonamide
|
|
C19H18ClNO3S |
详情 |
详情
|
(VIII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(IX) |
32599 |
methyl (E)-3-(6-[[(4-chlorophenyl)sulfonyl]amino]-2-vinyl-5,6,7,8-tetrahydro-1-naphthalenyl)-2-propenoate
|
|
C22H22ClNO4S |
详情 |
详情
|
(X) |
32600 |
methyl 3-(6-[[(4-chlorophenyl)sulfonyl]amino]-2-vinyl-5,6,7,8-tetrahydro-1-naphthalenyl)propanoate
|
|
C22H24ClNO4S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(II) Taxane intermediates (XIII) and (XIV) were prepared by two related ways. Wittig condensation of cyclopropanecarboxaldehyde (I) with methoxycarbonylmethylenetriphenyl phosphorane (II) gave methyl trans-cyclopropylacrylate (III). This was oxidized with potassium ferricyanide in the presence of OsO4 and the chiral catalyst 1,4-bis(9-O-dihydroquinidyl)phthalazine to furnish (2S,3R)-diol (IV). After conversion of (IV) to tosylate (V), its cyclization by means of K2CO3 produced epoxide (VI). Subsequent epoxide opening with NaN3 gave azide (VII), which was hydrogenated in the presence of Pd/C and di tert-butyl dicarbonate to furnish carbamate (VIII). Treatment of (VIII) with isopropenyl methyl ether (IX) and pyridinium tosylate, followed by ester hydrolysis, produced oxazolidine (X). This was coupled to protected taxane (XI) by means of DCC and DMAP to provide ester (XII). Oxazolidine hydrolysis in (XII) with formic acid, followed by reprotection of the amine with Boc2O, furnished intermediate (XIII). Optionally, the trichloroethoxycarbonyl groups of (XIII) were removed upon treatment with Zn and AcOH to produce intermediate (XIV).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26463 |
cyclopropanecarbaldehyde
|
1489-69-6 |
C4H6O |
详情 | 详情
|
(II) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(III) |
26464 |
methyl (E)-3-cyclopropyl-2-propenoate
|
|
C7H10O2 |
详情 |
详情
|
(IV) |
26465 |
methyl (2S,3R)-3-cyclopropyl-2,3-dihydroxypropanoate
|
|
C7H12O4 |
详情 |
详情
|
(V) |
26466 |
methyl (2S,3R)-3-cyclopropyl-3-hydroxy-2-[[(4-methylphenyl)sulfonyl]oxy]propanoate
|
|
C14H18O6S |
详情 |
详情
|
(VI) |
26467 |
methyl (2R,3R)-3-cyclopropyl-2-oxiranecarboxylate
|
|
C7H10O3 |
详情 |
详情
|
(VII) |
26468 |
methyl (2R,3S)-3-azido-3-cyclopropyl-2-hydroxypropanoate
|
|
C7H11N3O3 |
详情 |
详情
|
(VIII) |
26469 |
methyl (2R,3S)-3-[(tert-butoxycarbonyl)amino]-3-cyclopropyl-2-hydroxypropanoate
|
|
C12H21NO5 |
详情 |
详情
|
(IX) |
26470 |
3-methoxy-1-butene
|
|
C5H10O |
详情 |
详情
|
(X) |
26471 |
(4S,5R)-3-(tert-butoxycarbonyl)-4-cyclopropyl-2,2-dimethyl-1,3-oxazolidine-5-carboxylic acid
|
|
C14H23NO5 |
详情 |
详情
|
(XI) |
23892 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9,12-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C35H38Cl6O14 |
详情 |
详情
|
(XII) |
26472 |
methyl (9S,12S)-4-methoxy-12-[[(2S,5S,8S,11R)-5-(4-methoxybenzyl)-2,6,8,11,15,15-hexamethyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl](methyl)amino]-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate |
|
C49H59Cl6NO18 |
详情 |
详情
|
(XIII) |
26473 |
methyl (9S,12S)-4-methoxy-12-[[(2S,5S,8S,11R)-5-(4-methoxybenzyl)-2,6,8,11,15,15-hexamethyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl](methyl)amino]-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate |
|
C46H55Cl6NO18 |
详情 |
详情
|
(XIV) |
26474 |
methyl (9S,12S)-4-methoxy-12-[[(2S,5S,8S,11R)-5-(4-methoxybenzyl)-2,6,8,11,15,15-hexamethyl-4,7,10,13-tetraoxo-14-oxa-3,6,9,12-tetraazahexadec-1-anoyl](methyl)amino]-11-oxo-2-oxa-10-azatricyclo[12.2.2.1(3,7)]nonadeca-1(16),3(19),4,6,14,17-hexaene-9-carboxylate |
|
C40H53NO14 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XVII) The Stille coupling of the benzodioxanone (XII) with allyltributyltin (XIII) by means of trifurylphosphine (TFP) and Pd2(dba)3 gives the 6-allylsalicylic acid (XIV), which is esterified with the intermediate (XI) by means of DEAD and PPH3 in ethyl ether to yield the ester (XV). Hydrolysis of the lactol group of (XV) with Ac-OH affords the carbaldehyde (XVI), which is condensed with the phosphorane (XVII) to provide the unsaturated ester (XVIII). The silylation of the free OH groups of (XVIII) with Tbdms-OTf and lutidine gives the protected compound (XIX), which is submitted to a rig closing metathesis reaction catalyzed by a Ru catalyst in dichloromethane to yield the macrolactone (XX). The selective hydrolysis of the methyl ester group of (XX) by treatment with (Bu3Sn)2O in refluxing toluene affords the unsaturated carboxylic acid (XXI), which is treated with DPPA in refluxing benzene to provide the corresponding isocyanate (XXII). The reaction of the isocyanate group of (XXII) with (1Z,3Z)-hexadienyl cuprate, prepared in situ by reaction of Et-Li, CuBr/Me2S and acetylene, gives the silylated heptadienamide (XXIII), along with some pentanamide and nonatrienamide derivatives that are separated by chromatography. Finally, compound (XXIII) is desilylated by means of HF and pyridine in THF to provide the target salicylhalamide A.
【1】
Bauer, M.; Maier, M.E.; Synthesis of the core structure of salicylihalamide A by intramolecular Suzuki reaction. Org Lett 2002, 4, 13, 2205.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
56942 |
(4S,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-ol
|
|
C11H20O3 |
详情 |
详情
|
(XII) |
56943 |
2,2-dimethyl-4-oxo-4H-1,3-benzodioxin-5-yl trifluoromethanesulfonate
|
|
C11H9F3O6S |
详情 |
详情
|
(XIII) |
40599 |
Allyltributyltin; Tributyl-2-propenylstannane |
24850-33-7 |
C15H32Sn |
详情 | 详情
|
(XIV) |
56944 |
2-allyl-6-hydroxybenzoic acid
|
|
C10H10O3 |
详情 |
详情
|
(XV) |
56945 |
(4R,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-yl 2-allyl-6-hydroxybenzoate
|
|
C21H28O5 |
详情 |
详情
|
(XVI) |
56946 |
(1R,3R,4S)-3-hydroxy-4-methyl-1-(2-oxoethyl)-6-heptenyl 2-allyl-6-hydroxybenzoate
|
|
C20H26O5 |
详情 |
详情
|
(XVII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XVIII) |
56947 |
(1S,3R,4S)-3-hydroxy-1-[(E)-4-methoxy-4-oxo-2-butenyl]-4-methyl-6-heptenyl 2-allyl-6-hydroxybenzoate
|
|
C23H30O6 |
详情 |
详情
|
(XIX) |
56948 |
(1S,3R,4S)-3-{[tert-butyl(dimethyl)silyl]oxy}-1-[(E)-4-methoxy-4-oxo-2-butenyl]-4-methyl-6-heptenyl 2-allyl-6-{[tert-butyl(dimethyl)silyl]oxy}benzoate
|
|
C35H58O6Si2 |
详情 |
详情
|
(XX) |
56949 |
methyl (E)-4-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-2-butenoate
|
|
C33H54O6Si2 |
详情 |
详情
|
(XXI) |
56950 |
(E)-4-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-2-butenoic acid
|
|
C32H52O6Si2 |
详情 |
详情
|
(XXII) |
56951 |
(3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-3-[(E)-3-isocyanato-2-propenyl]-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one
|
|
C32H51NO5Si2 |
详情 |
详情
|
(XXIII) |
56952 |
(2Z,4Z)-N-[(E)-3-((3S,5R,6S)-5,14-bis{[tert-butyl(dimethyl)silyl]oxy}-6-methyl-1-oxo-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-3-yl)-1-propenyl]-2,4-heptadienamide
|
|
C38H61NO5Si2 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(XVI) A new Wittig condensation of aldehyde (XV) with phosphorane (XVI) in refluxing benzene gives the diunsaturated ester (XVII), which is reduced with DIBAL to the corresponding alcohol, and oxidated with DMP yielding the aldehyde (XVIII). The condensation of (XVIII) with the chiral propionyloxazolidinethione (XIX) by means of Sn(OTf)2 and 1-ethylpiperidine in dichloromethane affords the adduct (XX), which is treated with NaBH4 in THF to eliminate the chiral auxiliary and afford diol (XXI). The metalation of (XXI) with Bu3SnH and a Pd catalyst gives the vinylstannane (XXII), which is desilylated with TBAF in THF yielding the trihydroxycompound (XXIII). The condensation of stannane (XXIII) with iodobutenoic ester (XXIV) by means of a Pd catalyst affords the diunsaturated ester (XXV), which is selectively disilylated with TBDMSCl and imidazole in hot DMF to provide the disilyl ether (XXVI).
【1】
Guzzupe, A.N.; et al.; Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B. J Org Chem 2001, 66, 7, 2382.
|
【2】
Cuzzupe, A.N.; et al.; Total synthesis of (-)-reveromycin B. Org Lett 2000, 2, 2, 191.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XV) |
41549 |
(E)-4-[(2R,5S,7R,8S)-2-butyl-2-((1S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-2-methyl-2-butenal
|
n/a |
C27H46O4Si |
详情 | 详情
|
(XVI) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XVII) |
41550 |
methyl (2E,4E)-6-[(2R,5S,7R,8S)-2-butyl-2-((1S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-4-methyl-2,4-hexadienoate
|
n/a |
C30H50O5Si |
详情 | 详情
|
(XVIII) |
41551 |
(2E,4E)-6-[(2R,5S,7R,8S)-2-butyl-2-((1S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-4-methyl-2,4-hexadienal
|
|
C29H48O4Si |
详情 |
详情
|
(XIX) |
41552 |
1-[(4S)-4-isopropyl-2-thioxo-1,3-oxazolidin-3-yl]-1-propanone
|
|
C9H15NO2S |
详情 |
详情
|
(XX) |
41553 |
(2R,3S,4E,6E)-8-[(2R,5S,7R,8S)-2-butyl-2-((1S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-3-hydroxy-1-[(4S)-4-isopropyl-2-thioxo-1,3-oxazolidin-3-yl]-2,6-dimethyl-4,6-octadien-1-one
|
|
C38H63NO6SSi |
详情 |
详情
|
(XXI) |
41554 |
(2S,3S,4E,6E)-8-[(2R,5S,7R,8S)-2-butyl-2-((1S)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-2,6-dimethyl-4,6-octadiene-1,3-diol
|
|
C32H56O5Si |
详情 |
详情
|
(XXII) |
41555 |
(2S,3S,4E,6E)-8-[(2R,5S,7R,8S)-2-butyl-2-[(1S,2E)-1-[[tert-butyl(dimethyl)silyl]oxy]-3-(tributylstannyl)-2-propenyl]-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-2,6-dimethyl-4,6-octadiene-1,3-diol
|
n/a |
C44H84O5SiSn |
详情 | 详情
|
(XXIII) |
41556 |
(2S,3S,4E,6E)-8-[(2R,5S,7R,8S)-2-butyl-2-[(1S,2E)-1-hydroxy-3-(tributylstannyl)-2-propenyl]-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-2,6-dimethyl-4,6-octadiene-1,3-diol
|
n/a |
C38H70O5Sn |
详情 | 详情
|
(XXIV) |
41557 |
2-(trimethylsilyl)ethyl (E)-3-iodo-2-butenoate
|
n/a |
C9H17IO2Si |
详情 | 详情
|
(XXV) |
41558 |
2-(trimethylsilyl)ethyl (2E,4E,6S)-6-[(2R,5S,7R,8S)-2-butyl-7-[(2E,4E,6S,7S)-6,8-dihydroxy-3,7-dimethyl-2,4-octadienyl]-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-6-hydroxy-3-methyl-2,4-hexadienoate
|
n/a |
C35H60O7Si |
详情 | 详情
|
(XXVI) |
41559 |
2-(trimethylsilyl)ethyl (2E,4E,6S)-6-[(2R,5S,7R,8S)-7-((2E,4E,6S,7S)-6,8-bis[[tert-butyl(dimethyl)silyl]oxy]-3,7-dimethyl-2,4-octadienyl)-2-butyl-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-6-hydroxy-3-methyl-2,4-hexadienoate
|
n/a |
C47H88O7Si3 |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(XVI) The condensation of 3-(tert-butyldimethylsilyloxy)propanal (XXXIII) with the chiral borane (XXXIV) by means of H2O2 and NaHCO3 gives the chiral alcohol (XXXV), which is oxidized with OsO4 and NaIO4 to yield the aldehyde (XXXVI). The Wittig condensation of (XXXVI) with phosphorane (XVI) affords the heptenoic ester (XXXVII), which is reduced with H2 over Pd/C to provide the saturated hydroxy ester (XXXVIII). The cyclization of (XXXVIII) by means of PPTS in refluxing dichloromethane gives the lactone (XXXIX), which by reaction with Cp2TiMe2 yields the methylene derivative (I).
【1】
Guzzupe, A.N.; et al.; Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B. J Org Chem 2001, 66, 7, 2382.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41537 |
tert-butyl(dimethyl)[2-[(2R,3S)-3-methyl-6-methylenetetrahydro-2H-pyran-2-yl]ethoxy]silane; tert-butyl(dimethyl)silyl 2-[(2R,3S)-3-methyl-6-methylenetetrahydro-2H-pyran-2-yl]ethyl ether
|
|
C15H30O2Si |
详情 |
详情
|
(XVI) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(XXXIII) |
45546 |
3-[[tert-butyl(dimethyl)silyl]oxy]propanal
|
570-24-1 |
C9H20O2Si |
详情 | 详情
|
(XXXIV) |
50353 |
(E)-2-butenyl[bis[(1R,2R,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]]borane
|
|
C24H41B |
详情 |
详情
|
(XXXV) |
50354 |
(3R,4S)-1-[[tert-butyl(dimethyl)silyl]oxy]-4-methyl-5-hexen-3-ol
|
|
C13H28O2Si |
详情 |
详情
|
(XXXVI) |
50355 |
(2R,3R)-5-[[tert-butyl(dimethyl)silyl]oxy]-3-hydroxy-2-methylpentanal
|
|
C12H26O3Si |
详情 |
详情
|
(XXXVII) |
50356 |
methyl (E,4S,5R)-7-[[tert-butyl(dimethyl)silyl]oxy]-5-hydroxy-4-methyl-2-heptenoate
|
|
C15H30O4Si |
详情 |
详情
|
(XXXVIII) |
50357 |
methyl (4S,5R)-7-[[tert-butyl(dimethyl)silyl]oxy]-5-hydroxy-4-methylheptanoate
|
|
C15H32O4Si |
详情 |
详情
|
(XXXIX) |
50358 |
(5S,6R)-6-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-5-methyltetrahydro-2H-pyran-2-one
|
|
C14H28O3Si |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
(II) The condensation of benzylated D-arabinofuranose (I) with phosphonate (II) in benzene gives the unsaturated ester (III), which is reduced with DIBAL in dichloromethane, yielding the alcohol (IV). The selective monosilylation of (IV) with Tbdms-Cl, TEA and DMAP in DMF affords the silyl ether (V), which is treated with chloromethylsulfonyl chloride and pyridine to provide the sulfonate (VI). The reaction of (VI) with CsOAc and a crown ether in toluene gives the acetate (VII) with inversion of the configuration at the acetoxy group. Hydrolysis of the acetate group with NaOMe in THF yields the alcohol (VIII), which is chloromesylated as before, affording the sulfonate (IX). The treatment of (IX) with HCl in THF eliminates the silyl group, providing the unsaturated alcohol (X), which is epoxidized with tBu-OOH, Ti(OAc)4 and D-(-)-diethyl tartrate to give the chiral epoxide (XI). The reaction of (XI) with sodium azide in DMF yields the azido compound (XII) with the correct steric configuration. The reductive cyclization of (XII) with PPh3, H2 and Pd/C in methanol affords the pyrrolidine (XIII), which is N-protected with Boc2O and TEA in dichloromethane, providing the carbamate (XIV). Oxidative cleavage of the vicinal diol of (XIV) with Pb(OAc)4 in toluene gives the carbaldehyde (XV).
【1】
Takebayashi, M.; Kajimoto, T.; Kanie, O.; Hiranuma, S.; Kanie, Y.; Wong, C.-H.; A versatile synthetic strategy for the preparation and discovery of new iminocyclitols as inhibitors of glucosidases. J Org Chem 1999, 64, 14, 5280.
|
【2】
Wong, C.-H.; Liu, J. (Scripps Research Institute); Iminocyclitol inhibitors of hexoaminidase and glycosidase. WO 0068194 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47654 |
(3S,4S,5R)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl]tetrahydro-2-furanol
|
|
C26H28O5 |
详情 |
详情
|
(II) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(III) |
47655 |
methyl (E,4R,5R,6R)-4,5,7-tris(benzyloxy)-6-hydroxy-2-heptenoate
|
|
C29H32O6 |
详情 |
详情
|
(IV) |
47656 |
(E,4R,5R,6R)-4,5,7-tris(benzyloxy)-2-heptene-1,6-diol
|
|
C28H32O5 |
详情 |
详情
|
(V) |
47657 |
(2R,3R,4R,5E)-1,3,4-tris(benzyloxy)-7-[[tert-butyl(dimethyl)silyl]oxy]-5-hepten-2-ol
|
|
C34H46O5Si |
详情 |
详情
|
(VI) |
47658 |
(1R,2S,3R,4E)-2,3-bis(benzyloxy)-1-[(benzyloxy)methyl]-6-[[tert-butyl(dimethyl)silyl]oxy]-4-hexenyl chloromethanesulfonate
|
|
C35H47ClO7SSi |
详情 |
详情
|
(VII) |
47659 |
(1S,2S,3R,4E)-2,3-bis(benzyloxy)-1-[(benzyloxy)methyl]-6-[[tert-butyl(dimethyl)silyl]oxy]-4-hexenyl acetate
|
|
C36H48O6Si |
详情 |
详情
|
(VIII) |
47660 |
(2S,3R,4R,5E)-1,3,4-tris(benzyloxy)-7-[[tert-butyl(dimethyl)silyl]oxy]-5-hepten-2-ol
|
|
C34H46O5Si |
详情 |
详情
|
(IX) |
47661 |
(1S,2S,3R,4E)-2,3-bis(benzyloxy)-1-[(benzyloxy)methyl]-6-[[tert-butyl(dimethyl)silyl]oxy]-4-hexenyl chloromethanesulfonate
|
|
C35H47ClO7SSi |
详情 |
详情
|
(X) |
47662 |
(1S,2S,3R,4E)-2,3-bis(benzyloxy)-1-[(benzyloxy)methyl]-6-hydroxy-4-hexenyl chloromethanesulfonate
|
|
C29H33ClO7S |
详情 |
详情
|
(XI) |
47663 |
(1S,2S,3S)-2,3-bis(benzyloxy)-1-[(benzyloxy)methyl]-3-[(2S,3R)-3-(hydroxymethyl)oxiranyl]propyl chloromethanesulfonate
|
|
C29H33ClO8S |
详情 |
详情
|
(XII) |
47664 |
[(2R,3S)-3-[(1S,2R,3R)-3-azido-1,2,4-tris(benzyloxy)butyl]oxiranyl]methanol
|
|
C28H31N3O5 |
详情 |
详情
|
(XIII) |
47665 |
(1S)-1-[(2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl]pyrrolidinyl]-1,2-ethanediol
|
|
C28H33NO5 |
详情 |
详情
|
(XIV) |
47666 |
tert-butyl (2R,3R,4R,5R)-3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]-5-[(1S)-1,2-dihydroxyethyl]-1-pyrrolidinecarboxylate
|
|
C33H41NO7 |
详情 |
详情
|
(XV) |
47667 |
tert-butyl (2R,3R,4R,5S)-3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]-5-formyl-1-pyrrolidinecarboxylate
|
|
C32H37NO6 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(A) The Wittig reaction of 2,6-dinitrobenzaldehyde (I) with (ethoxycarbonylmethylene)triphenylphosphorane (A) produced methyl 2,6-dinitrocinnamate (II). Hydrogenation of the nitro groups and the olefinic double bond of (II) with concomitant cyclization furnished the tetrahydroquinolinone (III). Reductive alkylation of (III) with 6,6-dimethylheptadiynal (IV) and sodium cyanoborohydride produced the secondary amine (V). Finally, the N-methyl group was introduced by a second reductive alkylation with formaldehyde.
【1】
Masabuchi, K.; Umeda, I.; Taniguchi, M.; et al.; Synthesis and structure-activity relationships of novel fungal chitin synthase inhibitors. Bioorg Med Chem Lett 2000, 10, 13, 1459.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(I) |
39891 |
2,6-dinitrobenzaldehyde
|
606-31-5 |
C7H4N2O5 |
详情 | 详情
|
(II) |
44995 |
methyl (E)-3-(2,6-dinitrophenyl)-2-propenoate
|
|
C10H8N2O6 |
详情 |
详情
|
(III) |
44996 |
5-amino-3,4-dihydro-2(1H)-quinolinone
|
|
C9H10N2O |
详情 |
详情
|
(IV) |
44997 |
6,6-dimethyl-2,4-heptadiynal
|
|
C9H10O |
详情 |
详情
|
(V) |
44998 |
5-[(6,6-dimethyl-2,4-heptadiynyl)amino]-3,4-dihydro-2(1H)-quinolinone
|
|
C18H20N2O |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(LXVII) The reaction of the chiral dibenzoyloxy-dihydropyran (LXV) with H2SO4 and HgSO4 gives the unsaturated aldehyde (LXVI), which is condensed with the phosphorane (LXVII) to yield the hepatdienoic ester (LXVIII). The hydrogenation of (LXVIII) with H2 over Pd/C affords the heptanoic ester (LXIX), which is treated with Ts-Cl and pyridine to provide the tosyloxy derivative (LXX). The cyclization of (LXX) by means of K2CO3 gives the chiral epoxide (LXXI), which is condensed with vinylmagnesium bromide (LXXII) to yield 6(S)-hydroxy-8-nonenoic acid methyl ester (LXXIII). The oxidation of the terminal double bond of (LXXIII) with ozone affords the carbaldehyde (LXXIV), which is reduced with NaBH4 to provide 6(S),8-dihydroxyoctanoic acid methyl ester (XLVIII). The reaction of (XLVIII) with Ms-Cl and pyridine gives the dimesylate (XLIX), which is treated with Na2S2 to yield the lipoic acid methyl ester (L), which is hydrolyzed to the target acid with KOH in H2O.
【1】
Adger, B.; et al.; The synthesis of (R)-(+)-lipoic acid using a monooxygenase-catalysed biotransformation as the key step. Bioorg Med Chem 1997, 5, 2, 253.
|
【2】
Adger, B.; et al.; Application of enzymatic Baeyer-Villiger oxidations of 2-substituted cycloalkanones to the total synthesis of (R)-(+)-lipoic acid. J Chem Soc Chem Commun 1995, 15, 1563.
|
【3】
McCague, R.; Roberts, S.M.; Adger, B.M. (Celltech Group plc); Process for the production of lipoic acid. WO 9638437 .
|
【4】
Villani, F.; Nardi, A.; Salvi, A.; Falabella, G.; Synthesis of R(+)alpha-lipoic acid. WO 0230919 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XLVIII) |
57977 |
methyl (6S)-6,8-dihydroxyoctanoate
|
|
C9H18O4 |
详情 |
详情
|
(XLIX) |
57975 |
methyl (6S)-6,8-bis[(methylsulfonyl)oxy]octanoate
|
|
C11H22O8S2 |
详情 |
详情
|
(L) |
57976 |
methyl 5-[(3R)-1,2-dithiolan-3-yl]pentanoate
|
|
C9H16O2S2 |
详情 |
详情
|
(LXV) |
57990 |
(3R,4S)-4-(benzoyloxy)-3,4-dihydro-2H-pyran-3-yl benzoate
|
|
C19H16O5 |
详情 |
详情
|
(LXVI) |
57991 |
(1S,2E)-1-(hydroxymethyl)-4-oxo-2-butenyl benzoate
|
|
C12H12O4 |
详情 |
详情
|
(LXVII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(LXVIII) |
57992 |
(1S,2E,4E)-1-(hydroxymethyl)-6-methoxy-6-oxo-2,4-hexadienyl benzoate
|
|
C15H16O5 |
详情 |
详情
|
(LXIX) |
57993 |
(1S)-1-(hydroxymethyl)-6-methoxy-6-oxohexyl benzoate
|
|
C15H20O5 |
详情 |
详情
|
(LXX) |
57994 |
(1S)-6-methoxy-1-({[(4-methylphenyl)sulfonyl]oxy}methyl)-6-oxohexyl benzoate
|
|
C22H26O7S |
详情 |
详情
|
(LXXI) |
57995 |
methyl 5-[(2S)oxiranyl]pentanoate
|
|
C8H14O3 |
详情 |
详情
|
(LXXII) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(LXXIII) |
57996 |
methyl (6S)-6-hydroxy-8-nonenoate
|
|
C10H18O3 |
详情 |
详情
|
(LXXIV) |
57997 |
methyl (6S)-6-hydroxy-8-oxooctanoate
|
|
C9H16O4 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(II) Wittig reaction between aldehyde (I) and methyl(triphenylphosphoranylidene triphenyl)-acetate (II) in refluxing toluene provides E-olefin (III), which is then subjected to reaction with lithium derivative (IV) in THF to afford adduct (V). Benzyl groups of (V) are removed by hydrogenation over Pd(OH)2 in HOAc:MeOH:EtOAc to furnish amine (VI), which is then coupled to Z-Orn(Boc)-OH using 1-ethyl-3-dimethylaminopropylcarbodiimide (WSCD.HCl) and HOBt in CH2Cl2 to give beta-amino acid derivative (VIII). Saponification of the methyl ester group in (VIII) by means of LiOH, followed by condensation with HOBt by means of WSCD.HCl, yields activated ester (IX).
【1】
Hashimoto, S.; Hashimoto, M.; Tanaka, A.; Fujie, A.; Shigematsu, N.; Barrett, D.; An expedient synthesis of the amide analog of the potent antifungal lipopeptidolactone FR901469. Tetrahedron Lett 2001, 42, 4, 703.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50186 |
Myristaldehyde; Myristyl aldehyde; Tetradecanal; Myristic aldehyde trimer; Tetradecyl aldehyde
|
124-25-4 |
C14H28O |
详情 | 详情
|
(II) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(III) |
50187 |
methyl (E)-2-hexadecenoate
|
|
C17H32O2 |
详情 |
详情
|
(IV) |
30864 |
N-Benzyl-N-(1(R)-phenylethyl)amide lithium salt
|
|
C15H16LiN |
详情 |
详情
|
(V) |
50188 |
methyl (3R)-3-[benzyl[(1R)-1-phenylethyl]amino]hexadecanoate
|
|
C32H49NO2 |
详情 |
详情
|
(VI) |
50189 |
methyl (3R)-3-aminohexadecanoate
|
|
C17H35NO2 |
详情 |
详情
|
(VII) |
50190 |
(2S)-2-[[(benzyloxy)carbonyl]amino]-5-[(tert-butoxycarbonyl)amino]pentanoic acid
|
|
C18H26N2O6 |
详情 |
详情
|
(VIII) |
50191 |
methyl (3R)-3-([(2S)-2-[[(benzyloxy)carbonyl]amino]-5-[(tert-butoxycarbonyl)amino]pentanoyl]amino)hexadecanoate
|
|
C35H59N3O7 |
详情 |
详情
|
(IX) |
50192 |
tert-butyl (4S)-5-([(1R)-1-[2-(1H-1,2,3-benzotriazol-1-yloxy)-2-oxoethyl]tetradecyl]amino)-4-[[(benzyloxy)carbonyl]amino]-5-oxopentylcarbamate
|
|
C40H60N6O7 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(V) Treatment of gamma-butyrolactone (I) with N,O-dimethylhydroxylamine in the presence of dimethylaluminium chloride afforded the corresponding Weinreb amide (II), which was converted to the keto-alcohol (III) by addition of pentylmagnesium bromide. Swern oxidation of alcohol (III), followed by Wittig reaction of the resultant aldehyde (IV) with (methoxycarbonylmethylene)triphenylphosphorane (V), provided the unsaturated keto ester (VI). Subsequent scandium triflate-mediated peroxyhemiacetalyzation of ketone (VI) gave rise to (VII). Then, intramolecular Michael addition of the hydroperoxy ester (VII) in the presence of diethylamine generated the target cyclic peroxide.
【1】
Murakami, N.; Horii, T.; Itagaki, S.; Kobayashi, M.; Kawanishi, M.; New readily accessible peroxides with high anti-malarial potency. Bioorg Med Chem Lett 2002, 12, 1, 69.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20576 |
dihydro-2(3H)-furanone
|
96-48-0 |
C4H6O2 |
详情 | 详情
|
(II) |
59681 |
4-hydroxy-N-methoxy-N-methylbutanamide
|
|
C6H13NO3 |
详情 |
详情
|
(III) |
59682 |
1-hydroxy-4-nonanone
|
|
C9H18O2 |
详情 |
详情
|
(IV) |
59683 |
4-oxononanal
|
|
C9H16O2 |
详情 |
详情
|
(V) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(VI) |
59684 |
methyl (E)-6-oxo-2-undecenoate
|
|
C12H20O3 |
详情 |
详情
|
(VII) |
59685 |
methyl (E)-6-hydroperoxy-6-methoxy-2-undecenoate
|
|
C13H24O5 |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(VI) Dimethylaluminium chloride-catalyzed ring opening of butyrolactone (I) with N,O-dimethylhydroxylamine furnishes the N-methoxy amide (II). Subsequent condensation of the Weinreb amide (II) with pentylmagnesium bromide (III) gives rise to the hydroxy ketone (IV). Further oxidation of the primary alcohol function of (IV) under Swern conditions leads to keto aldehyde (V). Then, Wittig condensation of aldehyde (V) with (methoxycarbonylmethylene) triphenylphosphorane (VI) affords the unsaturated ester (VII). Treatment of (VII) with urea-hydrogen peroxide in the presence of scandium triflate generates the hydroperoxide compound (VIII), which undergoes further intramolecular ring closure in the presence of triethylamine, leading to the 1,2-dioxane (IX). Enzymatic hydrolysis of ester (IX) employing pig liver esterase gives acid (X). After activation of (X) as the corresponding pentafluorophenyl ester (XI), condensation with propylamine in pyridine provides the title N-propyl amide
【1】
Murakami, N.; Kawanishi, M.; Mostaqul, H.M.; Tsuruta, K.; Itagaki, S.; Horii, T.; Kobayashi, M.; Exploitation for new antimalarials using spongean peroxides as scaffolds. 22nd Symp Med Chem (Nov 27 2002, Shizuoka) 2002, Abst 1P-12.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20576 |
dihydro-2(3H)-furanone
|
96-48-0 |
C4H6O2 |
详情 | 详情
|
(II) |
59681 |
4-hydroxy-N-methoxy-N-methylbutanamide
|
|
C6H13NO3 |
详情 |
详情
|
(III) |
31871 |
bromo(pentyl)magnesium
|
693-25-4 |
C5H11BrMg |
详情 | 详情
|
(IV) |
59682 |
1-hydroxy-4-nonanone
|
|
C9H18O2 |
详情 |
详情
|
(V) |
59683 |
4-oxononanal
|
|
C9H16O2 |
详情 |
详情
|
(VI) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(VII) |
59684 |
methyl (E)-6-oxo-2-undecenoate
|
|
C12H20O3 |
详情 |
详情
|
(VIII) |
59685 |
methyl (E)-6-hydroperoxy-6-methoxy-2-undecenoate
|
|
C13H24O5 |
详情 |
详情
|
(IX) |
60083 |
methyl 2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetate
|
|
C13H24O5 |
详情 |
详情
|
(X) |
60084 |
2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetic acid
|
|
C12H22O5 |
详情 |
详情
|
(XI) |
60085 |
2,3,4,5,6-pentafluorophenyl 2-(6-methoxy-6-pentyl-1,2-dioxan-3-yl)acetate
|
|
C18H21F5O5 |
详情 |
详情
|
合成路线29
该中间体在本合成路线中的序号:
(IV) In an alternative method, 4-(t-butyldimethylsilyloxy)-3-(1-adamantyl)bromobenzene (I) undergoes Suzuki coupling with 4-formylbenzeneboronic acid (II) to provide the biphenyl aldehyde (III). Subsequent Wittig condensation of (III) with methyl triphenylphosphoranylideneacetate (IV) yields the unsaturated ester (V). This is finally hydrolyzed with LiOH to furnish the title compound.
【1】
Penco, S.; Merlini, L.; Giannini, G.; Vesci, L.; Pisano, C.; Dallavalle, S. (Sigma-Tau Industrie Farmaceutiche Riunite SpA); Retinoid derivs. with antiangiogenic, antitumoral and proapoptotic activities. WO 0311808 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63332 |
4-bromo-2-tricyclo[3.3.1.1~3,7~]dec-1-ylphenyl (1,1-dimethylethyl)(dimethyl)silyl ether; [(4-bromo-2-tricyclo[3.3.1.1~3,7~]dec-1-ylphenyl)oxy](1,1-dimethylethyl)dimethylsilane
|
|
C22H33BrOSi |
详情 |
详情
|
(II) |
61564 |
4-Formylphenylboronic acid; 4-Formylbenzeneboronic acid; 4-Boronobenzaldehyde; Benzaldehyde-4-boronic acid; 4-Formylphenylboronic acid
|
87199-17-5 |
C7H7BO3 |
详情 | 详情
|
(III) |
63333 |
4'-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}-3'-tricyclo[3.3.1.1~3,7~]dec-1-yl[1,1'-biphenyl]-4-carbaldehyde
|
|
C29H38O2Si |
详情 |
详情
|
(IV) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(V) |
63334 |
methyl 3-(4'-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}-3'-tricyclo[3.3.1.1~3,7~]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoate
|
|
C32H42O3Si |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(LXII) Conjugate addition of acrolein (LVIII) to nitromethane in the presence of KOH in MeOH followed by treatment with Na2S2O5 in H2O gives the nitrodisulfonate (LIX), which is hydrolyzed with glyoxylic acid by means of NaHCO3 to yield 4-nitroheptanedial (LX). Compound (LX) is cyclized in the presence of pyrrolidine and PhCOOH in CH2Cl2, providing 5-nitro-1-cyclohexenecarbaldehyde (LXI). Wittig reaction of aldehyde (LXI) with (methoxycarbonylmethylene)triphenylphosphorane (LXII) leads to conjugated ester (LXIII), which is finally saponified with NaOH .
Acid (XXXVII) can be alternatively prepared by Knoevenagel condensation of aldehyde (LXI) with malonic acid (LXIV) .
Hydrolysis of ethylene ketal (XVI) with aqueous p-toluenesulfonic acid gives ketone (LXV), which, without isolation, is converted to oxime (LXVI) by addition of hydroxylamine hydrochloride. Subsequent oxidation of oxime (LXVI) using sodium molybdate and H2O2 leads to compound (XXXVII) .
【1】
Wu, G., Sudhakar, A.R., Wang, T. et al. (Schering Corp.). Exo- and diastereo- selective synthesis of himbacine analogs. CA 2594871, EP 1848705, EP 2196454, EP 2196468, EP 2206697, JP 2008526972, US 2006247450, WO 2006076415. |
【2】
Thiruvengadam, T.K., Wang, T., Chiu, J.S., Liao, J. (Schering Corp.). Synthesis of 3-(5-nitrocyclohex-1-enyl)acrylic acid and esters thereof. EP 2035364, JP 2009542675, US 2008009651, WO 2008005344. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVI) |
68716 |
(E)-3-(1,4-dioxaspiro[4.5]dec-7-en-7-yl)acrylic acid |
|
C11H14O4 |
详情 | 详情
|
(XXXVII) |
68733 |
(E)-3-(5-nitrocyclohex-1-en-1-yl)acrylic acid;3-(5-nitro-1-cyclohexenyl)-2-propenoic acid |
|
C9H11NO4 |
详情 | 详情
|
(LVIII) |
17668 |
acrylaldehyde; Acrolein
|
107-02-8 |
C3H4O |
详情 | 详情
|
(LIX) |
68754 |
sodium 1,7-dihydroxy-4-nitroheptane-1,7-disulfonate |
|
C7H13NNa2O10S2 |
详情 | 详情
|
(LX) |
68755 |
4-nitroheptanedial |
|
C7H11NO4 |
详情 | 详情
|
(LXI) |
68756 |
5-nitro-1-cyclohexenecarbaldehyde |
|
C7H9NO3 |
详情 | 详情
|
(LXII) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(LXIII) |
68757 |
(E)-methyl 3-(5-nitrocyclohex-1-en-1-yl)acrylate |
|
C10H13NO4 |
详情 | 详情
|
(LXIV) |
12963 |
Malonic acid
|
141-82-2 |
C3H4O4 |
详情 | 详情
|
(LXV) |
68758 |
(E)-3-(5-oxocyclohex-1-en-1-yl)acrylic acid |
|
C9H10O3 |
详情 | 详情
|
(LXVI) |
68759 |
(E)-3-((E)-5-(hydroxyimino)cyclohex-1-en-1-yl)acrylic acid |
|
C9H11NO3 |
详情 | 详情
|